10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________________________

FORM 10-Q

___________________________________________

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 30, 2024

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number: 001-40348

___________________________________________

UiPath, Inc.

(Exact Name of Registrant as Specified in its Charter)

___________________________________________

Delaware	47-4333187
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
One Vanderbilt Avenue, 60th Floor New York, New York	10017
(Address of principal executive offices)	(Zip Code)
Registrant’s telephone number, including area code: (844) 432-0455

___________________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A common stock, par value $0.00001 per share	PATH	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  ☐    No  ☒

As of May 30, 2024, the registrant had 490,324,835 shares of Class A common stock and 82,452,748 shares of Class B common stock, each with a par value of $0.00001 per share, outstanding.

Table of Contents

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Comprehensive Loss	3
	Condensed Consolidated Statements of Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	32
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	34
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	Defaults Upon Senior Securities	35
Item 4.	Mine Safety Disclosures	35
Item 5.	Other Information	35
Item 6.	Exhibits	36
Signatures		37

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), about UiPath, Inc. and its consolidated subsidiaries (“UiPath,” the “Company,” “we,” “us,” or “our”) and our industry that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy, and plans and objectives of management for future operations, are forward-looking statements. In some cases, forward-looking statements can be identified because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the following:

•our expectations regarding our revenue, annualized renewal run-rate ("ARR"), expenses, and other operating results;

•our ability to effectively manage our growth and achieve or sustain profitability;

•our ability to acquire new customers and successfully retain existing customers;

•the ability of the UiPath Business Automation Platform to satisfy and adapt to customer demands and our ability to increase its adoption;

•our ability to grow our platform and release new functionality in a timely manner;

•future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;

•the costs and success of our marketing efforts and our ability to evolve and enhance our brand;

•our growth strategies;

•the estimated addressable market opportunity for our platform and for automation in general;

•our reliance on key personnel and our ability to attract, integrate, and retain highly-qualified personnel and execute management transitions, including our CEO transition;

•our ability to obtain, maintain, and enforce our intellectual property rights and any costs associated therewith;

•the effect of significant events with macroeconomic impacts, including but not limited to military conflicts and other changes in geopolitical relationships and inflationary cost trends, on our business, industry, and the global economy;

•our reliance on third-party providers of cloud-based infrastructure;

•our ability to compete effectively with existing competitors and new market entrants, including new, potentially disruptive technologies;

•the size and growth rates of the markets in which we compete; and

•the price volatility of our Class A common stock.

These forward-looking statements should not be unduly relied upon or regarded as predictions of future events. The forward-looking statements contained in this Quarterly Report on Form 10-Q are based on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled "Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q, and in the section titled "Risk Factors" and elsewhere in our Annual Report on Form 10-K for the fiscal year ended January 31, 2024 filed with the Securities and Exchange Commission ("SEC") on March 27, 2024 (the "2024 Form 10-K"). Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.

In addition, statements that “we believe,” and similar statements reflect our beliefs and opinions on the relevant subject, based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe such information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. Such statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited).

UiPath, Inc.

Condensed Consolidated Balance Sheets

Amounts in thousands except per share data

(unaudited)

	As of
	April 30, 2024		January 31, 2024
ASSETS
Current assets
Cash and cash equivalents	$	1,146,618	$	1,061,678
Restricted cash	438		438
Marketable securities	788,920		818,145
Accounts receivable, net of allowance for credit losses of $1,827 and $1,119, respectively	270,621		436,296
Contract assets	88,146		84,197
Deferred contract acquisition costs	76,309		74,678
Prepaid expenses and other current assets	98,146		104,980
Total current assets	2,469,198		2,580,412
Marketable securities, non-current	962		—
Contract assets, non-current	9,960		6,214
Deferred contract acquisition costs, non-current	145,175		154,317
Property and equipment, net	22,741		23,982
Operating lease right-of-use assets	60,458		56,072
Intangible assets, net	12,577		14,704
Goodwill	88,384		89,026
Deferred tax assets	3,900		4,678
Other assets, non-current	31,621		25,353
Total assets	$	2,844,976	$	2,954,758
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable	$	6,864	$	3,447
Accrued expenses and other current liabilities	84,793		83,997
Accrued compensation and employee benefits	40,663		137,442
Deferred revenue	465,216		486,805
Total current liabilities	597,536		711,691
Deferred revenue, non-current	150,934		161,027
Operating lease liabilities, non-current	62,772		58,713
Other liabilities, non-current	6,730		7,213
Total liabilities	817,972		938,644
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	—		—
Class A common stock, $0.00001 par value per share, 2,000,000 shares authorized; 496,893 and 492,660 shares issued; 490,115 and 486,820 shares outstanding, respectively	5		5
Class B common stock, $0.00001 par value per share, 115,741 shares authorized; 82,453 shares issued and outstanding	1		1
Treasury stock, at cost, 6,778 and 5,840 shares, respectively	(124,620)		(102,615)
Additional paid-in capital	4,089,795		4,024,079
Accumulated other comprehensive income	4,740		8,825
Accumulated deficit	(1,942,917)		(1,914,181)
Total stockholders’ equity	2,027,004		2,016,114
Total liabilities and stockholders’ equity	$	2,844,976	$	2,954,758

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

UiPath, Inc.

Condensed Consolidated Statements of Operations

Amounts in thousands except per share data

(unaudited)

	Three Months Ended April 30,
	2024		2023
Revenue:
Licenses	$	140,128	$	134,039
Subscription services	185,131		146,352
Professional services and other	9,853		9,197
Total revenue	335,112		289,588
Cost of revenue:
Licenses	2,601		2,547
Subscription services	36,754		23,078
Professional services and other	15,970		18,042
Total cost of revenue	55,325		43,667
Gross profit	279,787		245,921
Operating expenses:
Sales and marketing	180,139		160,406
Research and development	85,603		75,342
General and administrative	63,510		56,584
Total operating expenses	329,252		292,332
Operating loss	(49,465)		(46,411)
Interest income	13,830		13,848
Other income, net	10,679		4,294
Loss before income taxes	(24,956)		(28,269)
Provision for income taxes	3,780		3,632
Net loss	$	(28,736)	$	(31,901)
Net loss per share, basic and diluted	$	(0.05)	$	(0.06)
Weighted-average shares used in computing net loss per share, basic and diluted	569,925		557,878

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

UiPath, Inc.

Condensed Consolidated Statements of Comprehensive Loss

Amounts in thousands

(unaudited)

	Three Months Ended April 30,
	2024		2023
Net loss	$	(28,736)	$	(31,901)
Other comprehensive (loss) income, net of tax:
Unrealized (loss) gain on available-for-sale marketable securities, net	(511)		143
Foreign currency translation adjustments	(3,574)		2,319
Other comprehensive (loss) income, net	(4,085)		2,462
Comprehensive loss	$	(32,821)	$	(29,439)

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

UiPath, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

Amounts in thousands

(unaudited)

	Common Stock						Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total Stockholders’ Equity
	Class A			Class B
	Shares	Amount		Shares	Amount		Shares	Amount		Amount		Amount		Amount		Amount
Balance as of January 31, 2024	492,660	$	5	82,453	$	1	(5,840)	$	(102,615)	$	4,024,079	$	8,825	$	(1,914,181)	$	2,016,114
Issuance of common stock upon exercise of stock options	1,426	—		—	—		—	—		311		—		—		311
Issuance of common stock upon settlement of restricted stock units	3,843	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,317)	—		—	—		—	—		(29,944)		—		—		(29,944)
Charitable donation of Class A common stock	281	—		—	—		—	—		6,564		—		—		6,564
Repurchase of Class A Common Stock	—	—		—	—		(938)	(22,005)		—		—		—		(22,005)
Stock-based compensation	—	—		—	—		—	—		88,785		—		—		88,785
Other comprehensive loss, net	—	—		—	—		—	—		—		(4,085)		—		(4,085)
Net loss	—	—		—	—		—	—		—		—		(28,736)		(28,736)
Balance as of April 30, 2024	496,893	$	5	82,453	$	1	(6,778)	$	(124,620)	$	4,089,795	$	4,740	$	(1,942,917)	$	2,027,004

	Common Stock						Treasury Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Income		Accumulated Deficit		Total Stockholders’ Equity
	Class A			Class B
	Shares	Amount		Shares	Amount		Shares	Amount		Amount		Amount		Amount		Amount
Balance as of January 31, 2023	474,160	$	5	82,453	$	1	—	$	—	$	3,736,838	$	7,612	$	(1,824,298)	$	1,920,158
Issuance of common stock upon exercise of stock options	898	—		—	—		—	—		1,175		—		—		1,175
Issuance of common stock upon settlement of restricted stock units	4,246	—		—	—		—	—		—		—		—		—
Tax withholdings on settlement of restricted stock units	(1,463)	—		—	—		—	—		(25,697)		—		—		(25,697)
Charitable donations of Class A common stock	281	—		—	—		—	—		4,215		—		—		4,215
Stock-based compensation	—	—		—	—		—	—		85,125		—		—		85,125
Other comprehensive income, net	—	—		—	—		—	—		—		2,462		—		2,462
Net loss	—	—		—	—		—	—		—		—		(31,901)		(31,901)
Balance as of April 30, 2023	478,122	$	5	82,453	$	1	—	$	—	$	3,801,656	$	10,074	$	(1,856,199)	$	1,955,537

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

UiPath, Inc.

Condensed Consolidated Statements of Cash Flows

Amounts in thousands

(unaudited)

	Three Months Ended April 30,
	2024		2023
Cash flows from operating activities
Net loss	$	(28,736)	$	(31,901)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,902		5,616
Amortization of deferred contract acquisition costs	18,467		14,072
Net amortization on marketable securities	(9,268)		(4,097)
Stock-based compensation expense	88,727		85,048
Charitable donation of Class A common stock	6,564		4,215
Non-cash operating lease expense	3,476		3,071
Provision for deferred income taxes	569		(267)
Other non-cash (credits) charges, net	(966)		624
Changes in operating assets and liabilities:
Accounts receivable	162,444		141,557
Contract assets	(7,645)		660
Deferred contract acquisition costs	(12,437)		(15,499)
Prepaid expenses and other assets	(803)		(5,860)
Accounts payable	3,936		(2,130)
Accrued expenses and other liabilities	(4,195)		(10,547)
Accrued compensation and employee benefits	(96,403)		(93,390)
Operating lease liabilities, net	(3,912)		(2,946)
Deferred revenue	(24,683)		(20,885)
Net cash provided by operating activities	100,037		67,341
Cash flows from investing activities
Purchases of marketable securities	(323,137)		(215,391)
Maturities of marketable securities	360,141		78,955
Purchases of property and equipment	(1,238)		(1,870)
Other investing, net	—		2,754
Net cash provided by (used in) investing activities	35,766		(135,552)
Cash flows from financing activities
Repurchases of Class A common stock	(22,005)		—
Proceeds from exercise of stock options	312		1,187
Payments of tax withholdings on net settlement of equity awards	(28,959)		(25,902)
Net payments of tax withholdings on sell-to-cover equity award transactions	—		(645)
Proceeds from employee stock purchase plan contributions	4,916		4,730
Net cash used in financing activities	(45,736)		(20,630)
Effect of exchange rate changes	(5,127)		(1,702)
Net increase (decrease) in cash, cash equivalents, and restricted cash	84,940		(90,543)
Cash, cash equivalents, and restricted cash - beginning of period	1,062,116		1,402,119
Cash, cash equivalents, and restricted cash - end of period	$	1,147,056	$	1,311,576
Supplemental disclosure of cash flow information
Cash paid for interest	$	45	$	86
Cash paid for income taxes	7,391		6,218
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases included in accounts payable	50		65
Receivable from maturities of marketable securities included in prepaid expense and other current assets	—		20,315
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	4,304		1,996

The accompanying notes are an integral part of these consolidated financial statements.

5

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements

(unaudited)

1. Organization and Description of Business

Description of Business

UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

2. Summary of Significant Accounting Policies

Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2024 Form 10-K. There have been no significant changes to such policies during the three months ended April 30, 2024.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K.

The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.

The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period.

Fiscal Year

Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.

6

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Foreign Currency

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended April 30, 2024 and 2023, we recognized foreign currency transaction gains (losses) of $2.8 million and $(0.8) million, respectively.

Concentration of Risks

Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable.

We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2024 and January 31, 2024, 95% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan.

The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.

With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three months ended April 30, 2024 and 2023, no single customer accounted for 10% or more of our total revenue. As of April 30, 2024 and January 31, 2024, no single customer accounted for 10% or more of our accounts receivable.

Recently Issued Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

7

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

3. Revenue Recognition

Disaggregation of Revenue

The following tables summarize revenue by geographical region (dollars in thousands): 

	Three Months Ended April 30,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	153,111	46	%	$	123,452	43	%
Europe, Middle East, and Africa	104,627		31	%	96,931		33	%
Asia-Pacific (2)	77,374		23	%	69,205		24	%
Total revenue	$	335,112	100	%	$	289,588	100	%

(1)Revenue from the U.S. represented 42% and 38% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

(2)Revenue from Japan represented 13% and 13% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

Deferred Revenue

During the three months ended April 30, 2024 and 2023, we recognized $182.3 million and $150.6 million of revenue that was included in the deferred revenue balance as of January 31, 2024 and 2023, respectively.

Remaining Performance Obligations

Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of April 30, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,100.6 million, which consists of $616.2 million of billed consideration and $484.4 million of unbilled consideration. We expect to recognize 62% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter.

Deferred Contract Acquisition Costs

Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $18.5 million and $14.1 million for the three months ended April 30, 2024 and 2023, respectively, and is recorded in sales and marketing expense in the condensed consolidated statements of operations.

4. Marketable Securities

The following is a summary of our marketable securities (in thousands): 

	As of April 30, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	978	$	—	$	—	$	978
Treasury bills and U.S. government securities(1)	710,071		—		(506)		709,565
Corporate bonds(2)	24,778		—		(60)		24,718
Agency bonds	54,661		—		(40)		54,621
Total marketable securities	$	790,488	$	—	$	(606)	$	789,882
(1) Additional treasury bills with both amortized cost and estimated fair value of $19.8 million are included in cash and cash equivalents due to their original maturity of three months or less.
(2) Additional corporate bonds with both amortized cost and estimated fair value of $6.1 million are included in cash and cash equivalents due to their original maturity of three months or less.

8

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

	As of January 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Treasury bills and U.S. government securities	641,263		29		(100)		641,192
Corporate bonds	1,993		—		(2)		1,991
Agency bonds	174,990		—		(28)		174,962
Total marketable securities	$	818,246	$	29	$	(130)	$	818,145

As of April 30, 2024 and January 31, 2024, $1.0 million and none, respectively, of our marketable securities had remaining contractual maturities of one year or more.

As of April 30, 2024 and January 31, 2024, $3.1 million and $3.3 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2024 and January 31, 2024.

Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

5. Fair Value Measurement

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2024 and January 31, 2024 (in thousands): 

	As of April 30, 2024
	Level 1		Level 2		Total
Money market	$	499,276	$	—	$	499,276
Treasury bills	19,765		—		19,765
Corporate bonds	—		6,065		6,065
Total cash equivalents	519,041		6,065		525,106
Commercial paper	—		978		978
Treasury bills and U.S. government securities	709,565		—		709,565
Corporate bonds	—		24,718		24,718
Agency bonds	54,621		—		54,621
Total marketable securities	764,186		25,696		789,882
Total	$	1,283,227	$	31,761	$	1,314,988

	As of January 31, 2024
	Level 1		Level 2		Total
Money market	$	509,053	$	—	$	509,053
Total cash equivalents	509,053		—		509,053
Treasury bills and U.S. government securities	641,192		—		641,192
Corporate bonds	—		1,991		1,991
Agency bonds	174,962		—		174,962
Total marketable securities	816,154		1,991		818,145
Total	$	1,325,207	$	1,991	$	1,327,198

Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper and corporate bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for

9

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of April 30, 2024 or January 31, 2024.

6. Intangible Assets and Goodwill

Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of April 30, 2024 (dollars in thousands): 

	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,572	$	(18,166)	$	10,406	2.6
Customer relationships	8,228		(6,829)		1,399		1.2
Trade names and trademarks	271		(271)		—		0.0
Other intangibles	1,231		(459)		772		6.9
Total	$	38,302	$	(25,725)	$	12,577

Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands):

	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,807	$	(16,881)	$	11,926	2.8
Customer relationships	8,266		(6,306)		1,960		1.3
Trade names and trademarks	272		(266)		6		0.2
Other intangibles	1,231		(419)		812		7.0
Total	$	38,576	$	(23,872)	$	14,704

We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended April 30, 2024 and 2023 was $2.0 million and $2.1 million, respectively.

Expected future amortization expense related to intangible assets was as follows as of April 30, 2024 (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	4,615
Year ending January 31,
2026	4,079
2027	2,428
2028	1,153
2029	101
Thereafter	201
Total	$	12,577

10

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Goodwill

Changes in the carrying amount of goodwill during the three months ended April 30, 2024 were as follows (in thousands):

	Carrying Amount
Balance as of January 31, 2024	$	89,026
Effect of foreign currency translation	(642)
Balance as of April 30, 2024	$	88,384

7. Operating Leases

Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees.

Lease costs are presented below (in thousands):

	Three Months Ended April 30,
	2024		2023
Operating lease cost	$	3,476	$	3,071
Short-term lease cost	1,123		1,300
Variable lease cost	523		621
Sublease income (1)	—		(532)
Total	$	5,122	$	4,460

(1) Included in other income, net in the condensed consolidated statements of operations.

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:

	As of
	April 30, 2024		January 31, 2024
Weighted-average remaining lease term (years)	10.5		10.7
Weighted-average discount rate	7.2	%	7.1	%

Future undiscounted lease payments for our operating lease liabilities as of April 30, 2024 were as follows (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	9,097
Year ending January 31,
2026	12,110
2027	11,875
2028	10,444
2029	7,137
Thereafter	49,852
Total operating lease payments	100,515
Less: imputed interest	(29,519)
Total operating lease liabilities	$	70,996

11

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

As of April 30, 2024, we had non-cancellable commitments in the amount of $26.3 million related to operating leases of real estate facilities that have not yet commenced.

Current operating lease liabilities of $8.2 million and $8.4 million were included in accrued expenses and other current liabilities on our condensed consolidated balance sheets as of April 30, 2024 and January 31, 2024, respectively.

Supplemental cash flow information related to leases for the three months ended April 30, 2024 and 2023 was as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,653	$	2,615
Operating lease ROU assets obtained in exchange for new operating lease liabilities	7,044		1,993

8. Condensed Consolidated Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Prepaid expenses and service credits	$	76,695	$	87,781
Other current assets	21,451		17,199
Prepaid expenses and other current assets	$	98,146	$	104,980

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Computers and equipment	$	23,706	$	23,767
Leasehold improvements	24,307		21,756
Furniture and fixtures	6,708		6,640
Construction in progress	2,720		4,560
Other	631		632
Property and equipment, gross	58,072		57,355
Less: accumulated depreciation	(35,331)		(33,373)
Property and equipment, net	$	22,741	$	23,982

Depreciation expense for the three months ended April 30, 2024 and 2023 was $2.3 million and $3.0 million, respectively.

12

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Accrued expenses	$	22,256	$	18,458
Withholding tax from employee equity transactions	4,216		3,277
Employee stock purchase plan withholdings	8,483		3,618
Payroll taxes and other benefits payable	5,424		3,888
Income taxes payable	6,833		7,140
Value-added taxes payable	3,837		6,480
Operating lease liabilities, current	8,224		8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024)	5,570		5,570
Rebates payable to partners	6,364		7,289
Other	13,586		19,920
Accrued expenses and other current liabilities	$	84,793	$	83,997

9. Commitments and Contingencies

Letters of Credit

We had a total of $2.8 million and $2.6 million in letters of credit outstanding in favor of certain landlords for office space as of April 30, 2024 and January 31, 2024, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2026.

Indemnification

In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties.

These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of April 30, 2024 and January 31, 2024, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote.

Defined Contribution Plans

We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans was $6.2 million and $5.6 million for the three months ended April 30, 2024 and 2023, respectively.

Litigation

From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters which arise in the ordinary course of business. In accordance with ASC 450, Contingencies, we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.

UiPath and certain of its officers are currently parties to the following litigation matters:

13

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, then Co-CEO Daniel Dines, and CFO Ashim Gupta, captioned In re UiPath, Inc. Securities Litigation (the "Securities Action"). The initial complaint asserted claims under Sections 10(b) and 20(a) of the Exchange Act, and alleged that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. On January 26, 2024, the lead plaintiff in the Securities Action filed an amended complaint, and on March 26, 2024, filed a further amended complaint, which alleges Securities Act claims under Sections 11 and 15 as well as Exchange Act claims under Section 10(b), Rule 10b-5, and Section 20(a). In support of the Securities Act claims, the plaintiff alleges material misstatements and omissions in UiPath’s April 2021 Registration Statement, including regarding UiPath’s competitive position and its financial results. The operative complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and September 27, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. Defendants moved to dismiss the second amended complaint on April 23, 2024. Plaintiffs filed their opposition to defendants' motion to dismiss on May 21, 2024.

On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and then Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al. The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the Securities Action and by causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees and certain changes to UiPath’s corporate governance and internal controls. Similar cases were filed in the District of Delaware and in the Southern District of New York (together with Polilingua Limited v. Daniel Dines, et al, the "Derivative Litigations"). The Derivative Litigations are at an early stage; in each case the matter has been stayed, pending the outcome of the Court's decision on the defendants' motion to dismiss the Securities Action.

We have not recorded any accrual related to the aforementioned litigation matters as of April 30, 2024, as we believe a loss in these matters is neither probable nor estimable at this time.

Warranty

We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made.

Other Matters

Our indirect tax positions are subject to audit in multiple jurisdictions globally, with a key focus on our largest operational territories, including the U.S., Romania, India, and the U.K. Our Romanian subsidiary was subjected to audits by the Agenția Națională de Administrare Fiscală ("ANAF") for value-added tax and corporate income tax for the periods January 2020 through January 2022 and January 2018 through January 2022, respectively, which were completed during the three months ended April 30, 2024. With regard to the value-added tax audit, an assessment has been issued; we disagree with this assessment and are in the process of appealing. We have not recorded any reserves related to this audit as of April 30, 2024 as it is not probable that a material loss has been incurred. For additional information regarding the corporate income tax audit, refer to Note 12, Income Taxes.

14

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Non-Cancelable Purchase Obligations

In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and credits toward purchase of products and services from strategic alliance partners.

As of April 30, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	66,202
Year ending January 31,
2026	69,593
2027	23,856
2028	8,443
2029	17
Thereafter	1
Total	$	168,112

10. Stockholders’ Equity

Stock Repurchase Program

On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future.

During the three months ended April 30, 2024, we repurchased 0.9 million shares of our Class A common stock at an average price of $23.46 per share (inclusive of brokerage commission).

Charitable Donations of Class A Common Stock

We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. We contributed 0.3 million shares of our Class A common stock during the three months ended April 30, 2024 and 0.3 million shares of our Class A common stock during the three months ended April 30, 2023 to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $6.6 million and $4.2 million were recorded within general and administrative expense in the condensed consolidated statements of operations for the three months ended April 30, 2024 and 2023, respectively.

15

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Accumulated Other Comprehensive Income

For the three months ended April 30, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands):

	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2024	$	8,925	$	(100)	$	8,825
Other comprehensive loss, net of tax	(3,574)		(511)		(4,085)
Balance as of April 30, 2024	$	5,351	$	(611)	$	4,740

	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive income, net of tax	2,319		143		2,462
Balance as of April 30, 2023	$	10,550	$	(476)	$	10,074

11. Equity Incentive Plans and Stock-Based Compensation

2021 Stock Plan

In April 2021, prior to and in connection with our initial public offering ("IPO"), we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, RSAs, RSUs, PSUs, and other forms of awards. As of April 30, 2024, we have reserved 202.2 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase.

2021 Employee Stock Purchase Plan

In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of April 30, 2024, the ESPP authorizes the issuance of 27.2 million shares of our Class A common stock under purchase rights granted to our employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of the offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date.

16

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

Stock Options

Stock option activity during the three months ended April 30, 2024 was as follows:

	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	11,080	$	3.49	7.8	$	216,010
Granted	1,670	$	0.10
Exercised	(1,428)	$	0.22
Forfeited	(40)	$	0.10
Outstanding as of April 30, 2024	11,282	$	3.41	8.0	$	175,549
Vested and exercisable as of April 30, 2024	4,779	$	5.09	6.8	$	66,332

The weighted-average grant date fair value of stock options granted during the three months ended April 30, 2024 was $21.26 per share. The intrinsic value of stock options exercised during the three months ended April 30, 2024 was $31.4 million.

Unrecognized compensation expense associated with unvested stock options granted and outstanding as of April 30, 2024 was approximately $122.5 million, which is to be recognized over a weighted-average remaining period of 2.2 years.

Restricted Stock Units

RSU activity during the three months ended April 30, 2024 was as follows:

	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	31,272	$	19.89
Granted	9,479	$	21.45
Vested	(3,843)	$	21.22
Forfeited	(1,497)	$	20.76
Unvested as of April 30, 2024	35,411	$	20.13

The fair value of RSUs released during the three months ended April 30, 2024 was $87.4 million.

As of April 30, 2024, total unrecognized compensation expense related to unvested RSUs was approximately $661.6 million, which is to be recognized over a weighted-average remaining period of 2.4 years.

Employee Stock Purchase Plan Awards

As of April 30, 2024, total unrecognized compensation expense related to the ESPP was approximately $0.9 million, which is to be recognized over a weighted-average remaining period of 0.1 years.

Stock-Based Compensation Associated with Business Acquisition

At the closing of the acquisition of Re:infer LTD on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of

17

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

April 30, 2024, total unrecognized compensation expense related to these shares was $3.2 million, which is to be recognized over a weighted-average remaining period of 1.3 years.

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cost of subscription services revenue	$	4,276	$	3,178
Cost of professional services and other revenue	2,470		2,699
Sales and marketing	36,216		33,123
Research and development	29,142		24,773
General and administrative	16,623		21,275
Total	$	88,727	$	85,048

12. Income Taxes

Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences.

We had a provision for income taxes of $3.8 million, reflecting an effective tax rate of (15.1)%, and $3.6 million, reflecting an effective tax rate of (12.8)%, for the three months ended April 30, 2024 and 2023, respectively. For the three months ended April 30, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries.

The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the three months ended April 30, 2024, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. will not be realized. Accordingly, we have recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance.

As of April 30, 2024, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. Our tax positions are subject to income tax audits in multiple tax jurisdictions globally, with a currently open audit in India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. Our Romanian subsidiary was subjected to a corporate income tax audit by ANAF for the period from January 2018 through January 2022, which was completed during the three months ended April 30, 2024. Certain deductions have been disallowed, resulting in a proposed reduction of net operating loss carryforwards of approximately $66.7 million. We are in the process of appealing this disallowance. In addition, we have engaged in two bilateral transfer pricing negotiations for our transfer pricing model, one between the U.S. and Romania, and one between Japan and Romania. These negotiations are still underway and the authorities are in the process of determining the cost sharing allocations between the respective countries. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us.

In 2023, Romania adopted an alternative minimum tax that is applicable to all corporate taxpayers, including those reporting a net loss, for tax years commencing after January 1, 2024. As this tax is based on gross receipts,

18

UiPath, Inc.

Notes to Condensed Consolidated Financial Statements (Continued)

(unaudited)

associated expense is included in operating expenses in our condensed consolidated statements of operations, and is not accounted for as income taxes.

13. Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):

	Three Months Ended April 30,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(24,579)	$	(4,157)	$	(27,186)	$	(4,715)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	487,472		82,453		475,425		82,453
Net loss per share, basic and diluted	$	(0.05)	$	(0.05)	$	(0.06)	$	(0.06)

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	32,230	—	37,351	—
Outstanding stock options	10,946	—	13,883	—
Shares subject to repurchase from RSAs and early exercised stock options	28	—	63	—
Shares issuable under ESPP	690	—	897	—
Returnable shares issued in connection with business acquisition	274	—	427	—
Total	44,168	—	52,621	—

14. Subsequent Events

On May 3, 2024, we agreed to invest approximately $35.2 million, split between cash investment for equity and purchase of convertible bonds, in an initial seed round in H.AI (the “H company”), a France-based global foundation model and agentic artificial intelligence ("AI") company.

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and the related notes and the discussion under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the fiscal year ended January 31, 2024 included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 27, 2024 (the "2024 Form 10-K"). This discussion, particularly information with respect to our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, includes forward-looking statements that involve risks and uncertainties as described under the heading “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q. You should review the disclosure under the heading "Risk Factors" in this Quarterly Report on Form 10-Q and under Part I, Item 1A, "Risk Factors," in the 2024 Form 10-K for discussion of important factors that could cause our actual results to differ materially from those anticipated in these forward-looking statements.

Overview

First established in a Bucharest, Romania apartment in 2005, UiPath was incorporated in Delaware in 2015 as a company principally focused on building and managing automations and developing computer vision technology, which remains the foundation of our platform today. Since that time, we have evolved from our beginnings in robotic process automation ("RPA") into an end-to-end AI-powered Business Automation Platform through development and acquisitions, have launched new products, and have expanded our operations across the globe. Our vision is to enable automation across all knowledge work to accelerate human achievement.

The UiPath Business Automation Platform is The Foundation of Innovation™. We provide our customers with a robust set of capabilities that allow them to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale. Our platform enables customers to integrate AI with automation, enabling automation to take action based on learning and experience. It enables employees to quickly build automations for both existing and new processes and to automate a vast array of actions including, but not limited to, logging into applications, extracting information from documents, moving folders, filling in forms, reading emails, and updating information fields and databases. The ability of our platform to replicate steps performed by humans in executing business processes drives operational efficiencies and enables companies to deliver on key digital initiatives with greater speed, agility, and accuracy.

AI-powered automation is here, and its momentum is continuing to grow as organizations around the world begin to understand the combined power of automation and AI to drive efficiency and business outcomes. We aspire to be the defining business automation platform, advancing the evolution of automation and AI as a way of working and a catalyst for continuous reinvention.

20

Business Highlights for the Three Months Ended April 30, 2024:

•Revenue of $335.1 million increased 16% year-over-year.

•ARR of $1,507.7 million increased 21% year-over-year.

•Gross margin was 83% for the three months ended April 30, 2024, compared to 85% for the three months ended April 30, 2023.

•Cash flow from operations was $100.0 million for the three months ended April 30, 2024, compared to $67.3 million for the three months ended April 30, 2023.

•Cash and cash equivalents, restricted cash, and marketable securities were $1,936.9 million as of April 30, 2024, compared to $1,880.3 million as of January 31, 2024.

21

Macroeconomic Environment

As a corporation with a global presence, we are subject to risks and uncertainties caused by significant events with macroeconomic impacts, including, but not limited to, the impact of changes in geopolitical relationships, rising inflation and interest rates, monetary policy changes, and foreign currency fluctuations. Additionally, these macroeconomic impacts have generally disrupted the operations of our customers, prospective customers, and partners.

Internationally, we price our platform in currencies that may not be the functional currency. Accordingly, the heightened volatility of global markets has exposed us and will continue to expose us to foreign currency fluctuations, which may impact demand for our platform, our near-term results, the comparability of results to prior periods, and our ability to predict future results.

Further, cash, cash equivalents, and marketable securities represent a significant portion of our total assets, and the return on our cash, cash equivalents, and marketable securities is sensitive to changes in interest rates. Volatility in the interest rate environment may impact the amount of interest and other income reported on our condensed consolidated statements of operations, the comparability of these amounts to prior periods, and our ability to predict future profitability.

We continuously monitor the direct and indirect impacts of these circumstances on our business and financial results, as well as the overall global economy and geopolitical landscape.

Key Performance Metric

We monitor annualized renewal run-rate ("ARR") to help us measure and evaluate the effectiveness of our operations.

ARR is the key performance metric we use in managing our business because it illustrates our ability to acquire new subscription customers and to maintain and expand our relationships with existing subscription customers. We define ARR as annualized invoiced amounts per solution SKU from subscription licenses and maintenance and support obligations assuming no increases or reductions in customers' subscriptions. ARR does not include the costs we may incur to obtain such subscription licenses or provide such maintenance and support, and does not reflect any actual or anticipated reductions in invoiced value due to contract non-renewals or service cancellations other than for certain reserves, for example those for credit losses or disputed amounts. At April 30, 2024 and 2023, our ARR was $1,507.7 million and $1,248.9 million, respectively, representing a growth rate of 21%. Approximately 16% of this growth was due to new customers and 84% to existing customers. Our dollar-based net retention rate, which represents the net expansion of ARR from existing customers over the preceding 12 months, was 118% and 122% as of April 30, 2024 and 2023, respectively. We calculate dollar-based net retention rate as of a period end by starting with the ARR from the cohort of all customers as of 12 months prior to such period end ("Prior Period ARR"). We then calculate the ARR from these same customers as of the current period end ("Current Period ARR"). Current Period ARR includes any expansion and is net of contraction or attrition over the last 12 months, but does not include ARR from new customers in the current period. We then divide the total Current Period ARR by the total Prior Period ARR to arrive at the point-in-time dollar-based net retention rate.

Our ARR may fluctuate as a result of a number of factors, including customers’ satisfaction or dissatisfaction with our platform, pricing, competitive offerings, economic conditions, overall changes in our customers’ spending levels, and our ability to successfully execute on our strategic goals. ARR should be viewed independently of revenue and deferred revenue as ARR is an operating metric and is not intended to be combined with or to replace these items. For clarity, we use annualized invoiced amounts per solution SKU rather than revenue calculated in accordance with U.S. GAAP to calculate our ARR. Our invoiced amounts are not matched to transfer of control of the performance obligations associated with the underlying subscription licenses and maintenance and support obligations. This can result in timing differences between our GAAP revenue and ARR calculations. Generally speaking, our ARR calculation simply takes our invoiced amounts per solution SKU under a subscription license or maintenance agreement and divides that amount by the invoice term and multiplies by 365 days to derive the annualized value. In contrast, for our revenue calculated in accordance with GAAP, subscription licenses revenue derived from the sale of term-based licenses hosted on-premises is recognized at the point in time when the customer is able to use and benefit from our software, which is generally upon delivery to the customer or upon the commencement of the renewal term, and maintenance, support, and SaaS revenue is recognized ratably over the term of the arrangement. ARR is not a forecast of future revenue. Unlike ARR, future revenue can be impacted by contract start and end dates and duration. The timing of recognition of ARR is determined by contract billing structure, whereas billing structure will neither accelerate nor delay recognition of future revenue. For example, in a

22

multi-year contract invoiced upfront, ARR is the annualized invoiced amount per solution SKU related to the final year of the contract assuming no reserve is applied, whereas revenue is determined by total contract value and timing of satisfaction of the underlying performance obligations. ARR does not include invoiced amounts associated with perpetual licenses or professional services. Investors should not place undue reliance on ARR as an indicator of our future or expected results. Moreover, our presentation of ARR may differ from similarly titled metrics presented by other companies and may not be comparable to such other metrics.

A summary of ARR-related data at April 30, 2024 and 2023 is as follows:

	At April 30,
	2024			2023
	(dollars in thousands)
ARR	$	1,507,730		$	1,248,883
Incremental ARR (1)	258,847			271,816
Customers with ARR ≥ $1 million:
Number of customers	288			240
Percent of current period revenue	48		%	45		%
Customers with ARR ≥ $100 thousand:
Number of customers	2,092			1,858
Percent of current period revenue	85		%	82		%
Dollar-based net retention rate	118		%	122		%
(1) For the twelve months ended April 30, 2024 and 2023, respectively

Components of Results of Operations

Revenue

We derive revenue from the sale of: (1) software licenses for use of our proprietary software and related maintenance and support; (2) the right to access certain software products we host (i.e., SaaS); and (3) professional services.

We have a unified commercial offering for software products with both on-premise and cloud deployment options that allows customers the choice of either deployment option throughout the term of the contract. These Flex Offerings are comprised of three types of performance obligations: term license, maintenance and support, and SaaS.

Licenses

Our term licenses (typically sold as a portion of Flex Offerings) provide customers the right to use software for a specified period of time. Revenue for licenses is recognized at the point in time at which the customer is able to use and benefit from the software, which is generally upon delivery to the customer or upon commencement of the renewal term. As licenses revenue is recognized at a point in time, any shift in contract start dates and duration, for example due to lengthening sales cycles and increased deal scrutiny, will have a direct impact on our licenses revenue.

Subscription Services

We generate subscription services revenue through the provision of: (1) maintenance and support services, which include technical support and unspecified updates and upgrades on a when-and-if-available basis for our licenses, and (2) SaaS products (typically sold as a portion of Flex Offerings). Maintenance and support and SaaS products represent stand-ready obligations for which revenue is recognized ratably over the term of the arrangements.

Professional Services and Other

Professional services and other revenue consists of fees associated with professional services for process automation, customer education, and training services. Our professional services contracts are structured on a time and materials or fixed price basis, and the related revenue is recognized as the services are rendered.

23

Cost of Revenue

Licenses

Cost of licenses revenue consists of all direct costs to deliver our licenses to customers, amortization of software development costs related to our licenses, and amortization of acquired developed technology.

Subscription Services

Cost of subscription services revenue primarily consists of personnel-related expenses of our customer support and technical support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of subscription services revenue also includes third-party consulting services, hosting costs related to our SaaS products, amortization of acquired developed technology and capitalized software development costs related to SaaS products, depreciation, and allocated overhead. Overhead is allocated based on applicable headcount. We recognize these expenses as they are incurred. We expect cost of subscription services revenue to continue to increase in absolute dollars for the foreseeable future as our SaaS business grows. In the future, we expect further expansion of our cloud-based deployments. As sales of SaaS products become a larger percentage of our total revenue, we expect our gross margin to be impacted by increased hosting fees and cloud infrastructure costs.

Professional Services and Other

Cost of professional services and other revenue primarily consists of personnel-related expenses of our professional services team, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of professional services and other revenue also includes expenses related to subcontracted third-party services, depreciation, and allocated overhead. We recognize these expenses as they are incurred. We expect cost of professional services and other revenue to increase in absolute dollars for the foreseeable future.

Operating Expenses

Our operating expenses consist of sales and marketing, research and development, and general and administrative expenses. Personnel-related expenses are the most significant component of operating expenses and consist of salaries and bonuses, stock-based compensation expense, and employee benefit costs. Operating expenses also include allocated overhead.

Sales and Marketing

Sales and marketing expenses consist primarily of personnel-related expenses associated with our sales and marketing teams and related sales support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Sales and marketing expenses also include sales and partner commissions, marketing event costs, advertising costs, travel, trade shows, other marketing materials, and allocated overhead. We expect that over the longer term our sales and marketing expenses will decrease as a percentage of revenue, although this percentage may fluctuate from period to period due to timing and extent of expenses.

Research and Development

Research and development expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs, for our research and development employees, and allocated overhead. Research and development costs are expensed as incurred, with the exception of certain software development costs which are eligible for capitalization. We expect that our research and development expenses will increase in absolute dollars for the foreseeable future as we continue to invest in efforts to develop new technology and enhance the functionality and capabilities of our existing products and platform infrastructure. Our research and development expenses may fluctuate as a percentage of revenue from period to period due to the timing and extent of expenses.

General and Administrative

General and administrative expenses consist primarily of personnel-related expenses, including salaries and bonuses, stock-based compensation expense, and employee benefits costs, associated with our finance, legal, human resources, compliance, and other administrative teams, as well as accounting and legal professional services fees, other corporate-related expenses, and allocated overhead. We expect that over the longer term our

24

general and administrative expenses will decrease as a percentage of revenue, although this percentage may fluctuate from period to period due to timing and extent of expenses.

Interest Income

Interest income consists of interest earned on our cash and cash equivalents and marketable securities.

Other Income, Net

Other income, net primarily consists of foreign exchange gains and losses. Other income, net also includes amortization of discounts and premiums on marketable securities.

Provision For Income Taxes

Provision for income taxes consists of U.S. federal and state income taxes and income taxes in foreign jurisdictions in which we conduct business. We currently maintain a full valuation allowance on our U.S. federal and state, Romanian, and U.K. DTAs, as we have concluded that it is more likely than not that these DTAs will not be realized. Our effective tax rate is affected by tax rates in foreign jurisdictions and the relative amounts of income we earn in those jurisdictions, as well as by non-deductible expenses as permanent differences, and by changes in our valuation allowances.

25

Results of Operations

The following tables set forth selected condensed consolidated statement of operations data and such data as a percentage of total revenue for each of the periods indicated:

	Three Months Ended April 30,
	2024		2023
	(in thousands)
Revenue:
Licenses	$	140,128	$	134,039
Subscription services	185,131		146,352
Professional services and other	9,853		9,197
Total revenue	335,112		289,588
Cost of revenue:
Licenses (1)	2,601		2,547
Subscription services (1)(2)(3)	36,754		23,078
Professional services and other (2)(3)	15,970		18,042
Total cost of revenue	55,325		43,667
Gross profit	279,787		245,921
Operating expenses:
Sales and marketing (1)(2)(3)(4)	180,139		160,406
Research and development (2)(3)(4)	85,603		75,342
General and administrative (1)(2)(3)(4)	63,510		56,584
Total operating expenses	329,252		292,332
Operating loss	(49,465)		(46,411)
Interest income	13,830		13,848
Other income, net	10,679		4,294
Loss before income taxes	(24,956)		(28,269)
Provision for income taxes	3,780		3,632
Net loss	$	(28,736)	$	(31,901)
(1) Includes amortization of acquired intangible assets as follows:
Cost of licenses revenue	$	844	$	836
Cost of subscription services revenue	593		584
Sales and marketing	552		671
General and administrative	39		41
Total amortization of acquired intangible assets	$	2,028	$	2,132
(2) Includes stock-based compensation expense as follows:
Cost of subscription services revenue	$	4,276	$	3,178
Cost of professional services and other revenue	2,470		2,699
Sales and marketing	36,216		33,123
Research and development	29,142		24,773
General and administrative	16,623		21,275
Total stock-based compensation expense	$	88,727	$	85,048
(3) Includes employer payroll tax expense related to equity transactions as follows:
Cost of subscription services revenue	$	177	$	90
Cost of professional services and other revenue	66		71
Sales and marketing	1,223		1,224
Research and development	630		601
General and administrative	415		378
Total employer payroll tax expense related to equity transactions	$	2,511	$	2,364
(4) Includes restructuring expense as follows:
Sales and marketing	$	—	$	229
Research and development	—		285
General and administrative	—		375
Total restructuring expense	$	—	$	889

26

	Three Months Ended April 30,
	2024		2023
	(as a percentage of revenue)
Revenue:
Licenses	42	%	46	%
Subscription services	55	%	51	%
Professional services and other	3	%	3	%
Total revenue	100	%	100	%
Cost of revenue:
Licenses	1	%	1	%
Subscription services	11	%	8	%
Professional services and other	5	%	6	%
Total cost of revenue	17	%	15	%
Gross profit	83	%	85	%
Operating expenses:
Sales and marketing	53	%	55	%
Research and development	26	%	26	%
General and administrative	19	%	20	%
Total operating expenses	98	%	101	%
Operating loss	(15)	%	(16)	%
Interest income	4	%	5	%
Other income, net	3	%	1	%
Loss before income taxes	(8)	%	(10)	%
Provision for income taxes	1	%	1	%
Net loss	(9)	%	(11)	%

Comparison of the Three Months Ended April 30, 2024 and April 30, 2023

Revenue

	Three Months Ended April 30,
	2024		2023		Change		Change %
	(dollars in thousands)
Licenses	$	140,128	$	134,039	$	6,089	5	%
Subscription services	185,131		146,352		38,779		26	%
Professional services and other	9,853		9,197		656		7	%
Total revenue	$	335,112	$	289,588	$	45,524	16	%

Total revenue increased by $45.5 million, or 16%, for the three months ended April 30, 2024 compared to the three months ended April 30, 2023, primarily due to a $38.8 million increase in subscription services revenue, related in part to the transition to our Flex Offerings, and a $6.1 million increase in licenses revenue. As we continued to expand our sales efforts in the U.S. and internationally, our revenue increased across all regions. Of the growth in total revenue, 27% was attributable to new customers and 73% was attributable to existing customers. Of the growth in total revenue attributable to existing customers, $8.0 million resulted from contract modifications wherein the revenue recognized originated from our existing balance of remaining performance obligations. Subscription services revenue is recognized ratably over the subscription term; therefore, the increase in subscription services revenue is driven by both sales in prior periods for which we continue to provide maintenance and support and SaaS, and by new sales in the current period.

27

Cost of Revenue and Gross Margin

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
Licenses	$	2,601		$	2,547		$	54	2	%
Subscription services	36,754			23,078			13,676		59	%
Professional services and other	15,970			18,042			(2,072)		(11)	%
Total cost of revenue	$	55,325		$	43,667		$	11,658	27	%
Gross margin	83		%	85		%

Total cost of revenue increased by $11.7 million, or 27%, for the three months ended April 30, 2024 compared to the three months ended April 30, 2023, primarily due to a $13.7 million increase in cost of subscription services revenue, partially offset by a $2.1 million decrease in cost of professional services revenue. The increase in cost of subscription services revenue was primarily driven by a $6.4 million increase in personnel-related expenses, which included a $4.4 million increase in salary-related and bonus expenses associated with both increased headcount and merit increases, a $1.1 million increase in stock-based compensation expense, and a $1.0 million increase in employee insurance costs and employer payroll taxes. Cost of subscription services revenue was also impacted by a $4.8 million increase in hosting and software services costs as a result of increased usage and a $2.3 million increase in costs associated with the use of third-party vendors. The decrease in cost of professional services and other revenue was primarily driven by a $1.7 million decrease in personnel-related expenses, which included a $1.2 million decrease in salary-related and bonus expenses and a $0.2 million decrease in stock-based compensation expense. Cost of professional services and other revenue was also impacted by a $0.3 million decrease in costs associated with the use of third-party subcontractors to deliver professional services to our customers.

Our gross margin decreased to 83% for the three months ended April 30, 2024 compared to 85% for the three months ended April 30, 2023 due to decrease in proportion of higher-margin licenses revenue and increase in cost of subscription services revenue driven by increased hosting costs.

Operating Expenses

Sales and Marketing

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
Sales and marketing	$	180,139		$	160,406		$	19,733	12	%
Percentage of revenue	53		%	55		%

Sales and marketing expense increased by $19.7 million, or 12%, for the three months ended April 30, 2024 compared to the three months ended April 30, 2023. This increase was primarily attributable to a $12.7 million increase in personnel-related expenses, which included a $9.3 million increase in salary-related and bonus expenses as a result of both increased headcount and merit increases and a $3.1 million increase in stock-based compensation expense. Sales and marketing expense was also impacted by a $5.2 million increase in sales commission expenses as a result of higher amortization of capitalized contract acquisition costs and a $2.8 million aggregate increase in marketing and travel-related expenses mainly related to marketing events. These increases were partially offset by a $0.9 million decrease in depreciation and amortization and other administrative costs.

Research and Development

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
Research and development	$	85,603		$	75,342		$	10,261	14	%
Percentage of revenue	26		%	26		%

Research and development expense increased by $10.3 million, or 14%, for the three months ended April 30, 2024 compared to the three months ended April 30, 2023. The increase was primarily attributable to a $4.6 million

28

increase in personnel-related expenses, which included a $4.4 million increase in stock-based compensation expense and a $2.1 million increase in salary-related expenses associated with both increased headcount and merit increases, partially offset by a $1.9 million decrease in bonus expense. Research and development expense was also impacted by a $5.3 million increase in third-party software service and hosting costs as a result of increased usage.

General and Administrative

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
General and administrative	$	63,510		$	56,584		$	6,926	12	%
Percentage of revenue	19		%	20		%

General and administrative expense increased by $6.9 million, or 12%, for the three months ended April 30, 2024 compared to the three months ended April 30, 2023. This increase was primarily attributable to a $4.6 million increase in software service expenses, a $2.3 million increase in charitable donations mainly driven by the increased fair value of our Class A common shares to a donor-advised fund in the current year, and a $2.0 million increase due to a credit loss recovery recorded in the prior comparable fiscal quarter. General and administrative expense was also impacted by a $3.1 million decrease in personnel-related expenses, which included a $4.7 million decrease in stock-based compensation expense, partially offset by a $1.7 million increase in employee insurance costs.

Interest Income

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
Interest income	$	13,830		$	13,848		$	(18)	—	%
Percentage of revenue	4		%	5		%

Interest income remained constant for the three months ended April 30, 2024 compared to the three months ended April 30, 2023.

Other Income, Net

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
Other income, net	$	10,679		$	4,294		$	6,385	149	%
Percentage of revenue	3		%	1		%

Other income, net increased by $6.4 million for the three months ended April 30, 2024 compared to the three months ended April 30, 2023, primarily due to a $5.2 million increase in amortization on marketable securities and a $3.6 million increase in gains from foreign currency transactions, partially offset by $1.4 million of legal expense related to shareholder litigation.

Provision For Income Taxes

	Three Months Ended April 30,
	2024			2023			Change		Change %
	(dollars in thousands)
Provision for income taxes	$	3,780		$	3,632		$	148	4	%
Percentage of revenue	1		%	1		%

Provision for income taxes and effective tax rate remained relatively constant for the three months ended April 30, 2024 compared to the three months ended April 30, 2023.

29

Liquidity and Capital Resources

We have financed operations since our inception primarily through customer payments and net proceeds from sales of equity securities. Our principal uses of cash in recent periods have been to fund our operations, invest in capital expenditures, engage in various business acquisitions, and, more recently, repurchase shares of our Class A common stock. As of April 30, 2024, our principal sources of liquidity were cash, cash equivalents, and marketable securities totaling $1,936.5 million, and we had an accumulated deficit of $1,942.9 million. During the three months ended April 30, 2024, we reported a net loss of $28.7 million and net cash provided by operating activities of $100.0 million.

Our future capital requirements will depend on many factors, including our revenue growth rate, sales of our products and services, license renewal activity, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, the timing and extent of spending to support development efforts, the introduction of new and enhanced products, the continuing market adoption of our products, expenses associated with international expansion, the timing and extent of capital expenditures to invest in existing and new office spaces, and the timing and extent of stock repurchases. We may in the future enter into arrangements to acquire or invest in complementary businesses, products, and technologies. We may be required to seek additional equity or debt financing. In the event that we require additional financing, we may not be able to raise such financing on terms acceptable to us or at all. If we are unable to raise additional capital or generate cash flows necessary to expand our operations and invest in continued innovation, we may not be able to compete successfully, which would harm our business, operations, and financial condition.

We believe that our existing cash and cash equivalents, marketable securities, and payments from customers will be sufficient to fund our anticipated cash requirements for the next twelve months and the long term.

Credit Facility

On October 30, 2020 we entered into a $200.0 million senior secured revolving credit facility with a maturity date of October 30, 2023 (as subsequently amended, the “Credit Facility”) with HSBC Ventures USA Inc., Silicon Valley Bank, a division of First Citizens Bank & Trust Company (successor by purchase to the FDIC as receiver for Silicon Valley Bridge Bank, N.A. (as successor to Silicon Valley Bank)), Sumitomo Mitsui Banking Corporation, and Mizuho Bank, LTD (together, the "Lenders"). The Credit Facility contained certain customary covenants, including, but not limited to, those relating to additional indebtedness, liens, asset divestitures, and affiliate transactions.

We did not borrow under the Credit Facility at any time. In September 2023, we and the Lenders terminated the Credit Facility shortly prior to its original maturity date.

Stock Repurchase Program

On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Refer to Note 10, Stockholders' Equity—Stock Repurchase Program for further details.

Cash Flows

The following table summarizes our cash flows for the periods presented:

	Three Months Ended April 30,
	2024		2023
	(in thousands)
Net cash provided by operating activities (1)	$	100,037	$	67,341
Net cash provided by (used in) investing activities	$	35,766	$	(135,552)
Net cash used in financing activities	$	(45,736)	$	(20,630)
(1) Inclusive of:
Cash paid for employer payroll taxes related to employee equity transactions	$	(2,403)	$	(2,738)
Net payments of employee tax withholdings on stock option exercises	$	(12)	$	(765)
Cash paid for restructuring costs	$	(63)	$	(3,734)

30

Operating Activities

Our largest source of operating cash is cash generation from sales to our customers. Our primary uses of cash from operating activities are for personnel-related expenses, direct costs to deliver licenses and provide subscription and professional services, and marketing expenses. Until recently, our operating cash flows have generally been negative and we have supplemented working capital requirements primarily through net proceeds from the sale of equity securities.

Net cash provided by operating activities for the three months ended April 30, 2024 of $100.0 million was driven by cash collections from our customers, which were approximately 12% higher than during the three months ended April 30, 2023. These cash inflows were partially offset by cash payments for operating expenditures, primarily associated with the compensation of our teams, including fiscal year 2024 annual bonuses paid in the first quarter of fiscal year 2025. Other cash operating expenditures included payments for professional services, software, and office rent.

Net cash provided by operating activities for the three months ended April 30, 2023 of $67.3 million was driven by cash collections from our customers, partially offset by cash payments for operating expenditures, primarily associated with the compensation of our teams, including annual bonuses paid in the first quarter of fiscal year 2024. Other cash operating expenditures included payments related to our fiscal 2023 workforce restructuring, which was concluded during the second quarter of fiscal year 2024, and payments for professional services, software, and office rent.

Investing Activities

Net cash provided by investing activities for the three months ended April 30, 2024 of $35.8 million was primarily driven by $360.1 million in maturities of marketable securities, partially offset by $323.1 million in purchases of marketable securities.

Net cash used in investing activities for the three months ended April 30, 2023 of $135.6 million was primarily driven by $215.4 million in purchases of marketable securities and $1.9 million in capital expenditures, partially offset by $79.0 million in maturities of marketable securities.

Financing Activities

Net cash used in financing activities for the three months ended April 30, 2024 of $45.7 million was primarily driven by $29.0 million in payments of tax withholdings on net settlement of equity awards and $22.0 million in repurchases of Class A common stock under our stock repurchase program, partially offset by $4.9 million in proceeds from ESPP contributions.

Net cash used in financing activities for the three months ended April 30, 2023 of $20.6 million was driven by $25.9 million in payments of tax withholdings on the net settlement of equity awards and $0.6 million in net payments of tax withholdings on sell-to-cover equity award transactions, partially offset by $4.7 million in proceeds from ESPP contributions and $1.2 million in proceeds from the exercise of stock options.

Material Cash Requirements

Our material cash requirements predominantly relate to working capital requirements, including employee compensation and payment of employee tax withholdings on net settlement of equity awards, and material contractual obligations, including leases and purchase commitments.

As of April 30, 2024, accrued compensation and benefits of $40.7 million are included in current liabilities on our condensed consolidated balance sheet. Refer to Note 8, Consolidated Balance Sheet Components—Accrued Expenses and Other Current Liabilities for details of additional short-term payroll-related obligations included in accrued expenses and other current liabilities.

Refer to Note 7, Operating Leases for more detailed information regarding timing of future lease payments, and Note 9, Commitments and Contingencies—Non-Cancelable Purchase Obligations for more detailed information regarding timing of purchase commitments. There were no significant changes during the three months ended

31

April 30, 2024 from the contractual obligations disclosed in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” set forth in the 2024 Form 10-K.

Our stock repurchase program may also represent a material use of cash depending upon the number of shares repurchased, which is ultimately discretionary. Refer to Note 10, Stockholders' Equity—Stock Repurchase Program for further details.

Critical Accounting Estimates

There have been no material changes to our critical accounting estimates as compared to those disclosed in the 2024 Form 10-K.

Recent Accounting Pronouncements

See Note 2, Summary of Significant Accounting Policies—Recently Issued Accounting Pronouncements, included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is principally the result of fluctuations in interest rates and foreign currency exchange rates.

Interest Rate Risk

As of April 30, 2024, we had $1,146.6 million of cash and cash equivalents. Cash and cash equivalents consist of cash in banks, bank deposits, and money market accounts. In addition, we had $789.9 million of marketable securities, consisting of treasury bills and U.S. government securities, agency bonds, corporate bonds, and commercial paper. Such interest-earning instruments carry a degree of interest rate risk. The primary objectives of our investment activities are the preservation of capital, the fulfillment of liquidity needs, and the fiduciary control of cash. We do not enter into investments for trading or speculative purposes. The effect of a hypothetical 10% change in interest rates would not have had a material impact on our condensed consolidated financial statements for the three months ended April 30, 2024.

Foreign Currency Exchange Risk

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while translation of revenue and expenses is based on average monthly rates. Translation adjustments are recorded as a component of accumulated other comprehensive income (loss), and transaction gains and losses are recorded in other income (expense), net on our condensed consolidated financial statements. We have from time to time used foreign currency forward contracts to reduce our potential exposure to currency fluctuations. If we are not able to successfully mitigate the risks associated with currency fluctuations, our results of operations could be adversely affected. The estimated translation impact to our condensed consolidated financial statements of a hypothetical 10% change in foreign currency exchange rates would amount to $28.1 million for the three months ended April 30, 2024. For the three months ended April 30, 2024, approximately 55% of our revenues and approximately 35% of our expenses were denominated in non-U.S. dollar currencies, and we recognized net foreign currency transaction gains of $2.8 million.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. In addition, they are designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") as appropriate to allow timely decisions regarding required disclosure.

Pursuant to in Rules 13(a)-13(e) and 15(d)-15(e) under the Exchange Act, our management, with the participation of our CEO and CFO, performed an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation,

32

our CEO and CFO concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of April 30, 2024.

Changes in Internal Control Over Financial Reporting

During the three months ended April 30, 2024, no change in internal control over financial reporting was identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) of the Exchange Act that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at a reasonable assurance level. However, any control system, no matter how well designed and operated, can only provide reasonable, not absolute, assurance that its objectives will be met. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures and internal control over financial reporting, including resource constraints, errors in judgment, and the possibility that controls and procedures will be circumvented by collusion, by management override, or by mistake. Additionally, the design of any control system is based in part on management assumptions about the likelihood of future events, and there can be no assurance that the system will succeed in achieving its objectives under all potential future scenarios. As a result of these limitations, our management does not expect that our disclosure controls and procedures and internal control over financial reporting will prevent all potential errors or fraud or detect all potential misstatements due to error or fraud.

33

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

Refer to Note 9, Commitments and Contingencies—Litigation, to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for a description of current legal proceedings.

Item 1A. Risk Factors.

Our operations and financial results are subject to various risks and uncertainties, some of which are beyond our control. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risks discussed in the 2024 Form 10-K, including the disclosure under Part I, Item 1A, "Risk Factors,” which are risks we believe could materially affect our business, financial condition and future results. These are not the only risks we face. Other risks and uncertainties we are not currently aware of or that we currently consider immaterial also may materially adversely affect our business, financial condition and future results. Risks we have identified but currently consider immaterial could still materially adversely affect our business, financial condition, and future results if our assumptions about those risks are incorrect or if circumstances change.

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of the 2024 Form 10-K except as follows:

We are subject to numerous risks associated with the evolving market for products with AI capabilities.

The markets and use cases for products with AI capabilities have been rapidly evolving, are difficult to predict, and may impact demand for our products, our sales cycles, and the preferences of our customers and potential customers. The significant investments we have made to develop products and software to address what we believe will be increasing demand for AI capabilities may be insufficient, and we face significant hurdles, including whether demand will materialize, whether third-party software providers will develop functionality that allows their software to utilize the AI capabilities of our products, and whether we will be successful in developing products that can compete with offerings by established competitors.

We have invested in an early-stage global foundation model and agentic AI company and we may continue to invest in other potentially disruptive technologies in the future, through various vehicles such as equity or debt investments, joint ventures, or strategic partnerships. Such investments may not produce the expected results, may require more financial resources than anticipated, or may otherwise be unsuccessful, and the value of the investments may decline or our business may be adversely impacted.

Additionally, our use of AI technology in general may subject us to reputational, financial, legal, or regulatory risks. As we continue to incorporate AI technology into our products and services, any failures to address concerns relating to the responsible use of the evolving AI technology in our products and services may cause harm to our reputation or result in financial liability, and as such, may increase our costs to address or mitigate such risks and issues. AI technology may create ethical issues, generate defective algorithms, and present other risks that create challenges with respect to its adoption. In addition, evolving rules, regulations, and industry standards governing AI may require us to expend significant resources to modify, maintain, or align our business practices or products to comply with U.S. and non-U.S. rules and regulations, the nature of which cannot be determined at this time. Several jurisdictions around the globe, including the EU and certain U.S. states, have already proposed or enacted laws governing AI. U.S. federal agencies are likely to release AI regulations in the near future in light of the Biden administration's October 30, 2023 Executive Order on AI.

The regulatory environment surrounding the impact of the implementation of AI on our products and services may adversely affect our ability to produce and export products, and as a result, may cause harm to our reputation and result in financial liability.

Delays or difficulties associated with the design, implementation, or post-implementation use of our new enterprise resource planning ("ERP") system could adversely impact our business, financial condition, and results of operations.

We rely on information systems, particularly ERP technology, to manage our business, summarize our operating and financial results, and provide timely information to our management. We are currently engaged in a multi-year implementation of a new ERP system. This implementation is a complex project with broad scope, in

34

which we have invested and will continue to invest significant financial and human capital. Despite our efforts, we may experience delays, unexpected costs, or other difficulties as the implementation process continues. Further, although we plan to run our existing technology in parallel with the new ERP system for a period of time and to conduct extensive testing to ensure that the new ERP system is operating as intended, post-implementation disruptions to or difficulties in use of the new ERP could require us to incur additional costs, or could impair, among other things, our ability to record sales, process transactions, collect receivables, and produce timely and accurate historical and forecasted financial information, which could adversely impact our business, financial condition, and results of operations. Additionally, if the new ERP system does not ultimately operate as intended, the effectiveness of our internal control over financial reporting could be harmed.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Equity Securities

None.

Use of Proceeds from Initial Public Offering of Class A Common Stock

There has been no material change in the planned uses of proceeds from our IPO from those disclosed in the 2024 Form 10-K.

Issuer Purchase of Equity Securities

The following table presents our Class A common stock repurchase activity under our previously announced stock repurchase program for the three months ended April 30, 2024 (in thousands, except for per share data):

Period	Total Number of Shares Purchased	Average Price Paid Per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
February 1 - 29	673	$	23.54	673	$	381,657
March 1 - 31	265	$	23.20	265	$	375,515
April 1 - 30	—	$	—	—	$	375,515
Total	938			938

(1) Excludes brokerage commission.

(2) On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

35

Item 6. Exhibits.

Exhibit Number	Description
10.1†**	Advisory Agreement between UiPath, Inc. and Robert Enslin, executed May 28, 2024
31.1	Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1^	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2^	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
†	Indicates management contract or compensatory plan.
**	Certain information contained in this agreement has been omitted because it is the type that the registrant treats as private or confidential and/or is not material.
^	The certification furnished in Exhibit 32.1 hereto is deemed to accompany this Quarterly Report on Form 10-Q and is not deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in such filing.

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UiPath, Inc.
Date: June 3, 2024	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer (Principal Financial Officer)

37

EX-10.1

Exhibit 10.1

Certain information has been excluded from this exhibit pursuant to Item 601(a)(6) of Regulation S-K because

disclosure of such information would constitute a clearly unwarranted invasion of personal privacy. The following symbol is used to indicate where such information has been omitted: [*].

UIPATH ADVISORY AGREEMENT

This Advisory Agreement (“Agreement”) between UiPath, Inc. (“UiPath” or “Company”) and Robert Enslin (“Senior Advisor”) is entered into as of the date the last Party signs this Agreement. UiPath and Senior Advisor are each a “Party” and collectively the “Parties” to this Agreement.

SECTION 1. DEFINITIONS

1. “Affiliate” means any entity that directly or indirectly Controls, is Controlled by, or is under common Control with a Party, where “Control” means control of greater than 50% of the voting rights or equity interests of a Party.

2. “Confidential Information” (a) means non-public information disclosed by a Party (“Discloser”) to the other Party (“Recipient”) in connection with this Agreement, whether before or after the Effective Date, whether disclosed directly or indirectly, orally, in documentary form, by demonstration or otherwise, that is marked confidential or would reasonably be considered confidential under the circumstances, including information relating to Discloser’s past, present and future research, development, business activities, products, software, services, technical knowledge (including, but not limited to, data, reports, processes, financial information and projections, customer and supplier lists, business/marketing plans and strategies, services improvements, projects, proposals, tools, software, technology, trade secrets, designs, techniques, discoveries, practice methodologies and technologies, personnel information, computer readable media, etc.); and (b) excludes any information that (i) is or becomes public, through no fault of Recipient; (ii) was rightfully acquired by or already known to Recipient without an existing confidentiality obligation; or (iii) is independently developed by Recipient without the use of Discloser’s Confidential Information.

3. “Effective Date” is June 17, 2024.

4. “Compensation” shall mean the monetary fees received by Senior Advisor from UiPath for the Services provided under this Agreement.

5. “Intellectual Property Rights” means all current and future intellectual property rights including copyright and related rights, trademarks, designs, patents, rights to patent, rights to inventions, databases, trade secrets, trade names and domain names, Confidential Information, know-how, look and feel, trade dress and any other intellectual property rights or rights of a similar nature, including any application or right to apply for registration of any such rights and rights to apply for and be granted renewals or extensions of such rights, as well as the rights to claim priority therefrom, and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world and whether registered or unregistered.

6. “Services” means any services provided by Senior Advisor to UiPath, as mutually agreed by the Parties from time to time.

7. “Term” means from the Effective Date through and including September 27, 2024 and any extension in accordance with Section 2.1 of this Agreement.

8. “UiPath Data” means all data or information of UiPath or any of its Affiliates, accessed by Senior Advisor under this Agreement, which may include UiPath’s Confidential Information, as defined herein.

9. “UiPath Trademarks” means any UiPath and/or UiPath Affiliate trademarks, tradenames, service marks, symbols, logos, brand names and other proprietary indicia of any UiPath and/or UiPath Affiliate under common law, state law, federal law and laws of foreign countries, as the case may be.

SECTION 2. TERM AND TERMINATION

Exhibit 10.1

2.1. Term. The Term of this Agreement may be extended only by way of a written agreement between the Parties.

2.2. Termination for convenience. UiPath or the Senior Advisor, each in its sole discretion, may terminate this Agreement, in part or entirely for convenience, at any time, by giving a 30 (thirty) days prior written notice to the other Party and without any further liability, other than the obligation of the Company to the Senior Advisor for (i) reimbursement of expenses incurred prior to termination and (ii) any then-unpaid portion of the cash compensation described in Section 3.1 for the period through the date of termination, which shall be paid to Senior Advisor in a lump sum on the date of termination.

2.3. Effect of Termination. In the event of a termination of this Agreement, at the request and as specified by UiPath, Senior Advisor shall return to UiPath all UiPath Data, materials, tools, computer programs, equipment furnished by UiPath and Confidential Information in its possession or control and delete any records or copies thereof.

SECTION 3. COMPENSATION, PAYMENT AND INVOICES

3.1. Compensation. As consideration for the services to be provided by Senior Advisor pursuant to the Agreement, Senior Advisor will be paid $7,500 per week, paid in bi-weekly installments.

3.2. Expenses. UiPath shall pay Senior Advisor for expenditures authorized in the relevant authorization but not in excess of the amount so authorized. In addition, UiPath shall reimburse Senior Advisor for reasonable and necessary internal out-of-pocket expenses incurred by Senior Advisor (without mark-up) in the performance of Services that have been pre-approved by UiPath in writing. All approved travel expenses must be in compliance with the UiPath Travel Guidelines, which may be amended by UiPath from time to time upon prior notice from UiPath to Senior Advisor. UiPath also shall reimburse the Senior Advisor for his legal expenses in negotiating and entering into this Agreement. Senior Advisor shall not be entitled to reimbursement for any other expenses.

SECTION 4. CONFIDENTIALITY, PRIVACY AND CYBERSECURITY

4.1. Confidential Information. Senior Advisor will use UiPath’s Confidential Information only as necessary to perform its obligations under this Agreement and will only disclose UiPath’s Confidential Information to its Affiliates, its and its Affiliate’s employees, contractors or agents who need to know the Confidential Information and have agreed in writing to confidentiality obligations at least as protective as this Agreement (“Authorized Persons”).

4.2. Permitted disclosure. If Senior Advisor receives a court order or is otherwise required by law to disclose any Confidential Information, Senior Advisor will notify UiPath immediately upon receipt of such request so that UiPath has time to object and move for a protective order. Senior Advisor will file any Confidential Information under seal or request that the court or administrative body seal the Confidential Information prior to Senior Advisor’s disclosure. Notwithstanding anything to the contrary in this Agreement or otherwise, nothing shall limit Senior Advisor’s rights under applicable law to provide truthful information to any governmental entity or to file a charge with or participate in an investigation conducted by any governmental entity. This Agreement shall not be read as requiring Senior Advisor to waive any right Senior Advisor may have to receive an award for information provided to any governmental entity. Senior Advisor is hereby notified that the immunity provisions in Section 1833 of title 18 of the United States Code provide that an individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (1) in confidence to federal, state or local government officials, either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law, (2) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (3) to Senior Advisor’s attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and the trade secret is not disclosed except pursuant to court order.

4.3. Destruction. Senior Advisor will destroy all materials containing Confidential Information upon request of UiPath and will certify to the Discloser that all Confidential Information has been destroyed. Any Confidential Information retained post termination will not relieve Recipient of any obligation of confidentiality or non-use.

SECTION 5. INTELLECTUAL PROPERTY

5.1. Ownership. For the avoidance of any doubt, UiPath retains all rights to materials or information, including UiPath Data, UiPath Trademarks and all Intellectual Property Rights related to any of the foregoing, provided to Senior Advisor in the performance of this Agreement. Nothing in this Agreement shall be construed to grant Senior Advisor any license or other right in regard to the materials or information, including UiPath Data, UiPath Trademarks and all Intellectual Property Rights related to any of the foregoing. Senior Advisor shall not store or transfer for storage any UiPath Data without UiPath’s prior written consent. Senior Advisor has no Intellectual Property Rights or other claim to the UiPath Data and will cooperate with UiPath to protect UiPath’s Intellectual Property Rights and UiPath Data.

Exhibit 10.1

SECTION 6. REPRESENTATIONS AND WARRANTIES

6.1. Warranties. Senior Advisor represents and warrants to UiPath that: (a) it will act as specified in this Agreement, (b) it will perform all duties and responsibilities under this Agreement in a professional and competitive manner, (c) it will adopt the guidelines and policies of UiPath in relation to the responsibilities described in this Agreement, (d) it will perform any other tasks related to the scope of this Agreement as agreed with UiPath in writing, (e) its execution, delivery and performance of this Agreement will not violate any agreement to which it is a party or any of its properties or assets are bound or violate any applicable law, regulation or governmental order, including all UiPath internal policies and guidelines, and (f) it will comply with all applicable statutes, rules, regulations and orders of the United States.

SECTION 7. INDEMNITY AND LIABILITY

7.2. Limitation of liability. Neither Party will be liable to the other Party for any special, indirect, moral, consequential, incidental, punitive, or exemplary damages.

SECTION 8. SERVICES

8.1. Capacity and duties. Duties may include, but are not limited to, providing advisory services to UiPath, as reasonably and mutually agreed between UiPath and Senior Advisor.

SECTION 9. MISCELLANEOUS

9.1. Conflict of Interest. Senior Advisor represents that it is under no contractual or other restrictions or obligations which are inconsistent with the execution of this Agreement, or which will interfere with or impede the proper performance of this Agreement.

9.2. Relation. Senior Advisor is an independent contractor and is not an agent or employee of UiPath. Senior Advisor has no authority to bind UiPath by contract or otherwise.

9.3. Severability. Survival. Waiver. If any provisions of this Agreement are invalidated by a court of competent jurisdiction, they will be severed, and the rest of the Agreement will remain in full force and effect.

9.4. Governing Law. Venue. This Agreement is governed by the laws of the state of New York (expressly excluding conflict of laws). For any dispute arising out of or relating to this Agreement, if the Parties do not reach a settlement within sixty (60) calendar days, the Parties consent to personal jurisdiction in and the exclusive venue of the federal courts of New York, New York County, State of New York, United States of America.

9.5. Jury waiver clause. The Parties hereby irrevocably waive, to the fullest extent they may effectively do so, the defense of an inconvenient forum to the maintenance of such action or proceeding. TO THE FULLEST EXTENT PERMITTED BY LAW, EACH OF THE PARTIES WAIVES KNOWINGLY, VOLUNTARILY, IRREVOCABLY AND INTENTIONALLY ANY RIGHT IT MAY HAVE TO A JURY TRIAL IN RESPECT OF LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO THIS AGREEMENT.

9.6. Anti-corruption. Neither party has received or been offered any illegal or improper bribe, kickback, payment, gift, or thing of value from an employee or agent of the other party in connection with this Agreement. Reasonable gifts and entertainment provided in the ordinary course of business do not violate the above restriction. Senior Advisor hereby warrants that, while performing Services for UiPath it will strictly abide by UiPath’s policies and procedures on Anti-Bribery, and applicable laws.

9.7. Code of Conduct. Senior Advisor understands this Agreement is subject to the UiPath Global Partner Code.

9.8 Section 409A. It is intended that the provisions of this Agreement comply with Section 409A of the Code and the treasury regulations promulgated thereunder (“Section 409A”), and all provisions of this Agreement shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes and penalties under Section 409A. Each amount payable under this Agreement shall be treated as a separate payment for purposes of Section 409A. Except as specifically permitted by Section 409A or as otherwise specifically set forth in this Agreement, the reimbursements provided to Senior Advisor under this Agreement during any calendar year shall not affect the reimbursements to be provided to Senior Advisor under the relevant section of this Agreement in any other calendar year, and the right to such reimbursements cannot be liquidated or exchanged for any other benefit and shall be provided in accordance with Treas. Reg. Section 1.409A-3(i)(1)(iv) or any successor thereto. Further, in the case of reimbursement payments, reimbursement payments shall be made to Senior Advisor as soon as practicable following

Exhibit 10.1

the date that the applicable expense is incurred, but in no event later than the last day of the calendar year following the calendar year in which the underlying expense is incurred.

[Remainder of page intentionally blank]

Exhibit 10.1

UiPath	Senior Advisor
UiPath, Inc.	Senior Advisor
Address: 1 Vanderbilt Avenue, 60th Floor, New York, NY 10017 USA	Address: [*] [*]
Tax No. and/or VAT No: 47-4333187
Email: contractnotice@uipath.com	Email: [*]
By: Brad Brubaker	By: Robert Enslin
Title: Chief Legal Officer	Title: Senior Advisor
Date: 5/28/2024	Date: 5/28/2024
Authorized signature:	Authorized signature:
/s/ Brad Brubaker	/s/ Robert Enslin

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel Dines, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: June 3, 2024	By:	/s/ Daniel Dines
		Daniel Dines
		Chief Executive Officer, Founder, and Chairman

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ashim Gupta, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of UiPath, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors:

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: June 3, 2024	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended April 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel Dines, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 3, 2024	By:	/s/ Daniel Dines
		Daniel Dines
		Chief Executive Officer, Founder, and Chairman

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of UiPath, Inc. (the “Company”) on Form 10-Q for the quarter ended April 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ashim Gupta, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: June 3, 2024	By:	/s/ Ashim Gupta
		Ashim Gupta
		Chief Financial Officer

XML

Cover - shares	3 Months Ended
	Apr. 30, 2024	May 30, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2024
Document Transition Report	false
Entity File Number	001-40348
Entity Registrant Name	UiPath, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-4333187
Entity Address, Address Line One	One Vanderbilt Avenue, 60th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10017
City Area Code	844
Local Phone Number	432-0455
Title of 12(b) Security	Class A common stock, par value$0.00001 per share
Trading Symbol	PATH
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001734722
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--01-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		490,324,835
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		82,452,748

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Current assets
Cash and cash equivalents	$ 1,146,618	$ 1,061,678
Restricted cash	438	438
Marketable securities	788,920	818,145
Accounts receivable, net of allowance for credit losses of $1,827 and $1,119, respectively	270,621	436,296
Contract assets	88,146	84,197
Deferred contract acquisition costs	76,309	74,678
Prepaid expenses and other current assets	98,146	104,980
Total current assets	2,469,198	2,580,412
Marketable securities, non-current	962	0
Contract assets, non-current	9,960	6,214
Deferred contract acquisition costs, non-current	145,175	154,317
Property and equipment, net	22,741	23,982
Operating lease right-of-use assets	60,458	56,072
Intangible assets, net	12,577	14,704
Goodwill	88,384	89,026
Deferred tax assets	3,900	4,678
Other assets, non-current	31,621	25,353
Total assets	2,844,976	2,954,758
Current liabilities
Accounts payable	6,864	3,447
Accrued expenses and other current liabilities	84,793	83,997
Accrued compensation and employee benefits	40,663	137,442
Deferred revenue	465,216	486,805
Total current liabilities	597,536	711,691
Deferred revenue, non-current	150,934	161,027
Operating lease liabilities, non-current	62,772	58,713
Other liabilities, non-current	6,730	7,213
Total liabilities	817,972	938,644
Commitments and contingencies (Note 9)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized; none issued and outstanding	0	0
Treasury stock, at cost, $6,778 and $5,840 shares, respectively	(124,620)	(102,615)
Additional paid-in capital	4,089,795	4,024,079
Accumulated other comprehensive income	4,740	8,825
Accumulated deficit	(1,942,917)	(1,914,181)
Total stockholders’ equity	2,027,004	2,016,114
Total liabilities and stockholders’ equity	2,844,976	2,954,758
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Accounts receivable, allowance for doubtful accounts	$ 1,827	$ 1,119
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	20,000	20,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock, at cost (in shares)	6,778	5,840
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	496,893	492,660
Common stock, shares outstanding (in shares)	490,115	486,820
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	115,741	115,741
Common stock, shares issued (in shares)	82,453	82,453
Common stock, shares outstanding (in shares)	82,453	82,453

XML

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenue:
Total revenue	$ 335,112	$ 289,588
Cost of revenue:
Total cost of revenue	55,325	43,667
Gross profit	279,787	245,921
Operating expenses:
Sales and marketing	180,139	160,406
Research and development	85,603	75,342
General and administrative	63,510	56,584
Total operating expenses	329,252	292,332
Operating loss	(49,465)	(46,411)
Interest income	13,830	13,848
Other income, net	10,679	4,294
Loss before income taxes	(24,956)	(28,269)
Provision for income taxes	3,780	3,632
Net loss	$ (28,736)	$ (31,901)
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)
Weighted-average shares used in computing net loss per share, basic (in shares)	569,925	557,878
Weighted-average shares used in computing net loss per share, diluted (in shares)	569,925	557,878
Licenses
Revenue:
Total revenue	$ 140,128	$ 134,039
Cost of revenue:
Total cost of revenue	2,601	2,547
Subscription services
Revenue:
Total revenue	185,131	146,352
Cost of revenue:
Total cost of revenue	36,754	23,078
Professional services and other
Revenue:
Total revenue	9,853	9,197
Cost of revenue:
Total cost of revenue	$ 15,970	$ 18,042

XML

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (28,736)	$ (31,901)
Other comprehensive (loss) income, net of tax:
Unrealized (loss) gain on available-for-sale marketable securities, net	(511)	143
Foreign currency translation adjustments	(3,574)	2,319
Other comprehensive (loss) income, net	(4,085)	2,462
Comprehensive loss	$ (32,821)	$ (29,439)

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023				474,160	82,453	0
Beginning balance at Jan. 31, 2023	$ 1,920,158			$ 5	$ 1	$ 0	$ 3,736,838	$ 7,612	$ (1,824,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				898
Issuance of common stock upon exercise of stock options	1,175						1,175
Issuance of common stock upon settlement of restricted stock units (in shares)				4,246
Tax withholdings on settlement of restricted stock units (in shares)				(1,463)
Tax withholdings on settlement of restricted stock units	(25,697)						(25,697)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	4,215						4,215
Stock-based compensation	85,125						85,125
Other comprehensive (loss) income, net	2,462							2,462
Net loss	(31,901)	$ (27,186)	$ (4,715)						(31,901)
Ending balance (in shares) at Apr. 30, 2023				478,122	82,453	0
Ending balance at Apr. 30, 2023	1,955,537			$ 5	$ 1	$ 0	3,801,656	10,074	(1,856,199)
Beginning balance (in shares) at Jan. 31, 2024		492,660	82,453	492,660	82,453	(5,840)
Beginning balance at Jan. 31, 2024	$ 2,016,114			$ 5	$ 1	$ (102,615)	4,024,079	8,825	(1,914,181)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,428			1,426
Issuance of common stock upon exercise of stock options	$ 311						311
Issuance of common stock upon settlement of restricted stock units (in shares)				3,843
Tax withholdings on settlement of restricted stock units (in shares)				(1,317)
Tax withholdings on settlement of restricted stock units	(29,944)						(29,944)
Charitable donation of Class A common stock (in shares)				281
Charitable donation of Class A common stock	6,564						6,564
Repurchase of Class A common stock (in shares)				(900)		(938)
Repurchase of Class A Common Stock	(22,005)					$ (22,005)
Stock-based compensation	88,785						88,785
Other comprehensive (loss) income, net	(4,085)							(4,085)
Net loss	(28,736)	$ (24,579)	$ (4,157)						(28,736)
Ending balance (in shares) at Apr. 30, 2024		496,893	82,453	496,893	82,453	(6,778)
Ending balance at Apr. 30, 2024	$ 2,027,004			$ 5	$ 1	$ (124,620)	$ 4,089,795	$ 4,740	$ (1,942,917)

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities
Net loss	$ (28,736)	$ (31,901)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,902	5,616
Amortization of deferred contract acquisition costs	18,467	14,072
Net amortization on marketable securities	(9,268)	(4,097)
Stock-based compensation expense	88,727	85,048
Charitable donation of Class A common stock	6,564	4,215
Non-cash operating lease expense	3,476	3,071
Provision for deferred income taxes	569	(267)
Other non-cash (credits) charges, net	(966)	624
Changes in operating assets and liabilities:
Accounts receivable	162,444	141,557
Contract assets	(7,645)	660
Deferred contract acquisition costs	(12,437)	(15,499)
Prepaid expenses and other assets	(803)	(5,860)
Accounts payable	3,936	(2,130)
Accrued expenses and other liabilities	(4,195)	(10,547)
Accrued compensation and employee benefits	(96,403)	(93,390)
Operating lease liabilities, net	(3,912)	(2,946)
Deferred revenue	(24,683)	(20,885)
Net cash provided by operating activities	100,037	67,341
Cash flows from investing activities
Purchases of marketable securities	(323,137)	(215,391)
Maturities of marketable securities	360,141	78,955
Purchases of property and equipment	(1,238)	(1,870)
Other investing, net	0	2,754
Net cash provided by (used in) investing activities	35,766	(135,552)
Cash flows from financing activities
Repurchases of Class A common stock	(22,005)	0
Proceeds from exercise of stock options	312	1,187
Payments of tax withholdings on net settlement of equity awards	(28,959)	(25,902)
Net payments of tax withholdings on sell-to-cover equity award transactions	0	(645)
Proceeds from employee stock purchase plan contributions	4,916	4,730
Net cash used in financing activities	(45,736)	(20,630)
Effect of exchange rate changes	(5,127)	(1,702)
Net increase (decrease) in cash, cash equivalents, and restricted cash	84,940	(90,543)
Cash, cash equivalents, and restricted cash - beginning of period	1,062,116	1,402,119
Cash, cash equivalents, and restricted cash - end of period	1,147,056	1,311,576
Supplemental disclosure of cash flow information
Cash paid for interest	45	86
Cash paid for income taxes	7,391	6,218
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases included in accounts payable	50	65
Receivable from maturities of marketable securities included in prepaid expense and other current assets	0	20,315
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid	$ 4,304	$ 1,996

XML

Organization and Description of Business

3 Months Ended

Apr. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Description of Business

Organization and Description of Business

Description of Business

UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York, New York. Our AI-powered UiPath Business Automation Platform offers a robust set of capabilities that allows our customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission critical automation program at scale.

XML

Summary of Significant Accounting Policies

3 Months Ended

Apr. 30, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Our significant accounting policies are discussed in greater scope and detail in Note 2, Summary of Significant Accounting Policies, in the notes to consolidated financial statements included in the 2024 Form 10-K. There have been no significant changes to such policies during the three months ended April 30, 2024.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K.

The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.

The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period.

Fiscal Year

Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.

Foreign Currency

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations. For the three months ended April 30, 2024 and 2023, we recognized foreign currency transaction gains (losses) of $2.8 million and $(0.8) million, respectively.

Concentration of Risks

Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable.

We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2024 and January 31, 2024, 95% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan.

The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.

With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three months ended April 30, 2024 and 2023, no single customer accounted for 10% or more of our total revenue. As of April 30, 2024 and January 31, 2024, no single customer accounted for 10% or more of our accounts receivable.

Recently Issued Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

XML

Revenue Recognition

3 Months Ended

Apr. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Revenue Recognition

Disaggregation of Revenue

The following tables summarize revenue by geographical region (dollars in thousands): 

	Three Months Ended April 30,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	153,111	46	%	$	123,452	43	%
Europe, Middle East, and Africa	104,627		31	%	96,931		33	%
Asia-Pacific (2)	77,374		23	%	69,205		24	%
Total revenue	$	335,112	100	%	$	289,588	100	%

(1)Revenue from the U.S. represented 42% and 38% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

(2)Revenue from Japan represented 13% and 13% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

Deferred Revenue

During the three months ended April 30, 2024 and 2023, we recognized $182.3 million and $150.6 million of revenue that was included in the deferred revenue balance as of January 31, 2024 and 2023, respectively.

Remaining Performance Obligations

Our remaining performance obligations are comprised of licenses, subscription services, and professional services and other revenue not yet delivered. As of April 30, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $1,100.6 million, which consists of $616.2 million of billed consideration and $484.4 million of unbilled consideration. We expect to recognize 62% of our remaining performance obligations as revenue over the next 12 months, and the remainder thereafter.

Deferred Contract Acquisition Costs

Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $18.5 million and $14.1 million for the three months ended April 30, 2024 and 2023, respectively, and is recorded in sales and marketing expense in the condensed consolidated statements of operations.

XML

Marketable Securities

3 Months Ended

Apr. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Marketable Securities

Marketable Securities

The following is a summary of our marketable securities (in thousands): 

	As of April 30, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	978	$	—	$	—	$	978
Treasury bills and U.S. government securities(1)	710,071		—		(506)		709,565
Corporate bonds(2)	24,778		—		(60)		24,718
Agency bonds	54,661		—		(40)		54,621
Total marketable securities	$	790,488	$	—	$	(606)	$	789,882
(1) Additional treasury bills with both amortized cost and estimated fair value of $19.8 million are included in cash and cash equivalents due to their original maturity of three months or less.
(2) Additional corporate bonds with both amortized cost and estimated fair value of $6.1 million are included in cash and cash equivalents due to their original maturity of three months or less.

	As of January 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Treasury bills and U.S. government securities	641,263		29		(100)		641,192
Corporate bonds	1,993		—		(2)		1,991
Agency bonds	174,990		—		(28)		174,962
Total marketable securities	$	818,246	$	29	$	(130)	$	818,145

As of April 30, 2024 and January 31, 2024, $1.0 million and none, respectively, of our marketable securities had remaining contractual maturities of one year or more.

As of April 30, 2024 and January 31, 2024, $3.1 million and $3.3 million, respectively, of interest receivable was included in prepaid expenses and other current assets on the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivable as of April 30, 2024 and January 31, 2024.

Unrealized losses during the periods presented are a result of changes in market conditions. We do not believe that any unrealized losses are attributable to credit-related factors based on our evaluation of available evidence. To determine whether a decline in value is related to credit loss, we evaluate, among other factors, the extent to which the fair value is less than the amortized cost basis and any adverse conditions specifically related to an issuer of a security or its industry.

XML

Fair Value Measurement

3 Months Ended

Apr. 30, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurement

Fair Value Measurement

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2024 and January 31, 2024 (in thousands): 

	As of April 30, 2024
	Level 1		Level 2		Total
Money market	$	499,276	$	—	$	499,276
Treasury bills	19,765		—		19,765
Corporate bonds	—		6,065		6,065
Total cash equivalents	519,041		6,065		525,106
Commercial paper	—		978		978
Treasury bills and U.S. government securities	709,565		—		709,565
Corporate bonds	—		24,718		24,718
Agency bonds	54,621		—		54,621
Total marketable securities	764,186		25,696		789,882
Total	$	1,283,227	$	31,761	$	1,314,988

	As of January 31, 2024
	Level 1		Level 2		Total
Money market	$	509,053	$	—	$	509,053
Total cash equivalents	509,053		—		509,053
Treasury bills and U.S. government securities	641,192		—		641,192
Corporate bonds	—		1,991		1,991
Agency bonds	174,962		—		174,962
Total marketable securities	816,154		1,991		818,145
Total	$	1,325,207	$	1,991	$	1,327,198

Our money market funds, treasury bills and U.S. government securities, and agency bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify commercial paper and corporate bonds as Level 2 because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for

the identical underlying security which may not be actively traded. None of our financial instruments were classified in the Level 3 category as of April 30, 2024 or January 31, 2024.

XML

Intangible Assets and Goodwill

3 Months Ended

Apr. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

Intangible Assets and Goodwill

Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of April 30, 2024 (dollars in thousands): 

	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,572	$	(18,166)	$	10,406	2.6
Customer relationships	8,228		(6,829)		1,399		1.2
Trade names and trademarks	271		(271)		—		0.0
Other intangibles	1,231		(459)		772		6.9
Total	$	38,302	$	(25,725)	$	12,577

Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands):

	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,807	$	(16,881)	$	11,926	2.8
Customer relationships	8,266		(6,306)		1,960		1.3
Trade names and trademarks	272		(266)		6		0.2
Other intangibles	1,231		(419)		812		7.0
Total	$	38,576	$	(23,872)	$	14,704

We record amortization expense associated with acquired developed technology in cost of licenses revenue and cost of subscription services revenue, trade names and trademarks in sales and marketing expense, customer relationships in sales and marketing expense, and other intangibles in general and administrative expense in the condensed consolidated statements of operations. Amortization of acquired intangible assets for the three months ended April 30, 2024 and 2023 was $2.0 million and $2.1 million, respectively.

Expected future amortization expense related to intangible assets was as follows as of April 30, 2024 (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	4,615
Year ending January 31,
2026	4,079
2027	2,428
2028	1,153
2029	101
Thereafter	201
Total	$	12,577

Goodwill

Changes in the carrying amount of goodwill during the three months ended April 30, 2024 were as follows (in thousands):

	Carrying Amount
Balance as of January 31, 2024	$	89,026
Effect of foreign currency translation	(642)
Balance as of April 30, 2024	$	88,384

XML

Operating Leases

3 Months Ended

Apr. 30, 2024

Leases [Abstract]

Operating Leases

Operating Leases

Our operating leases consist of real estate and vehicles and have remaining lease terms of one year to 14 years. For purposes of calculating operating lease liabilities, lease terms may be deemed to include options to extend the lease when it is reasonably certain that we will exercise those options. Our operating lease arrangements do not contain any material restrictive covenants or residual value guarantees.

Lease costs are presented below (in thousands):

	Three Months Ended April 30,
	2024		2023
Operating lease cost	$	3,476	$	3,071
Short-term lease cost	1,123		1,300
Variable lease cost	523		621
Sublease income (1)	—		(532)
Total	$	5,122	$	4,460

(1) Included in other income, net in the condensed consolidated statements of operations.

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:

	As of
	April 30, 2024		January 31, 2024
Weighted-average remaining lease term (years)	10.5		10.7
Weighted-average discount rate	7.2	%	7.1	%

Future undiscounted lease payments for our operating lease liabilities as of April 30, 2024 were as follows (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	9,097
Year ending January 31,
2026	12,110
2027	11,875
2028	10,444
2029	7,137
Thereafter	49,852
Total operating lease payments	100,515
Less: imputed interest	(29,519)
Total operating lease liabilities	$	70,996

As of April 30, 2024, we had non-cancellable commitments in the amount of $26.3 million related to operating leases of real estate facilities that have not yet commenced.

Current operating lease liabilities of $8.2 million and $8.4 million were included in accrued expenses and other current liabilities on our condensed consolidated balance sheets as of April 30, 2024 and January 31, 2024, respectively.

Supplemental cash flow information related to leases for the three months ended April 30, 2024 and 2023 was as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,653	$	2,615
Operating lease ROU assets obtained in exchange for new operating lease liabilities	7,044		1,993

XML

Condensed Consolidated Balance Sheet Components

3 Months Ended

Apr. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidated Balance Sheet Components

Condensed Consolidated Balance Sheet Components

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Prepaid expenses and service credits	$	76,695	$	87,781
Other current assets	21,451		17,199
Prepaid expenses and other current assets	$	98,146	$	104,980

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Computers and equipment	$	23,706	$	23,767
Leasehold improvements	24,307		21,756
Furniture and fixtures	6,708		6,640
Construction in progress	2,720		4,560
Other	631		632
Property and equipment, gross	58,072		57,355
Less: accumulated depreciation	(35,331)		(33,373)
Property and equipment, net	$	22,741	$	23,982

Depreciation expense for the three months ended April 30, 2024 and 2023 was $2.3 million and $3.0 million, respectively.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Accrued expenses	$	22,256	$	18,458
Withholding tax from employee equity transactions	4,216		3,277
Employee stock purchase plan withholdings	8,483		3,618
Payroll taxes and other benefits payable	5,424		3,888
Income taxes payable	6,833		7,140
Value-added taxes payable	3,837		6,480
Operating lease liabilities, current	8,224		8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024)	5,570		5,570
Rebates payable to partners	6,364		7,289
Other	13,586		19,920
Accrued expenses and other current liabilities	$	84,793	$	83,997

XML

Commitments and Contingencies

3 Months Ended

Apr. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Letters of Credit

We had a total of $2.8 million and $2.6 million in letters of credit outstanding in favor of certain landlords for office space as of April 30, 2024 and January 31, 2024, respectively. These letters of credit renew annually and expire on various dates through fiscal year 2026.

Indemnification

In the ordinary course of business, we may provide indemnification of varying scope and terms to customers, vendors, directors, and officers with respect to certain matters, including, but not limited to, losses arising out of our breach of such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties.

These indemnification provisions may survive termination of the underlying agreement and the potential amount of future payments we could be required to make under these indemnification provisions may not be subject to maximum loss clauses. The maximum potential amount of future payments we could be required to make under these indemnification provisions is indeterminable. As of April 30, 2024 and January 31, 2024, we have not accrued a liability for these indemnification arrangements because the likelihood of incurring a payment obligation, if any, in connection with these indemnification arrangements was remote.

Defined Contribution Plans

We sponsor retirement plans for qualifying employees, including a 401(k) plan in the U.S. and defined contribution plans in certain other countries, to which we make matching contributions. Our total matching contributions to all defined contribution plans was $6.2 million and $5.6 million for the three months ended April 30, 2024 and 2023, respectively.

Litigation

From time to time, we may be involved in lawsuits, claims, investigations, and proceedings, consisting of intellectual property, commercial, employment, and other matters which arise in the ordinary course of business. In accordance with ASC 450, Contingencies, we make a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated.

UiPath and certain of its officers are currently parties to the following litigation matters:

On September 6, 2023, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against UiPath, then Co-CEO Daniel Dines, and CFO Ashim Gupta, captioned In re UiPath, Inc. Securities Litigation (the "Securities Action"). The initial complaint asserted claims under Sections 10(b) and 20(a) of the Exchange Act, and alleged that defendants made material misstatements and omissions, including regarding UiPath’s competitive position and its financial results. On January 26, 2024, the lead plaintiff in the Securities Action filed an amended complaint, and on March 26, 2024, filed a further amended complaint, which alleges Securities Act claims under Sections 11 and 15 as well as Exchange Act claims under Section 10(b), Rule 10b-5, and Section 20(a). In support of the Securities Act claims, the plaintiff alleges material misstatements and omissions in UiPath’s April 2021 Registration Statement, including regarding UiPath’s competitive position and its financial results. The operative complaint is purportedly brought on behalf of a putative class of persons who purchased or otherwise acquired UiPath common stock between April 21, 2021 and September 27, 2022. It seeks unspecified monetary damages, costs and attorneys’ fees, and other unspecified relief as the Court deems appropriate. Defendants moved to dismiss the second amended complaint on April 23, 2024. Plaintiffs filed their opposition to defendants' motion to dismiss on May 21, 2024.

On November 30, 2023, a purported shareholder derivative lawsuit was filed in the United States District Court for the Eastern District of New York against UiPath, as nominal defendant, and then Co-CEO Daniel Dines, CFO Ashim Gupta, and several of UiPath’s current and former directors. The case is captioned Polilingua Limited v. Daniel Dines, et al. The lawsuit alleges that the individual defendants breached their fiduciary duties and committed other alleged misconduct in connection with the statements at issue in the Securities Action and by causing UiPath to repurchase shares at allegedly inflated prices. The plaintiff seeks unspecified damages and/or restitution on behalf of UiPath, as well as costs and attorneys’ fees and certain changes to UiPath’s corporate governance and internal controls. Similar cases were filed in the District of Delaware and in the Southern District of New York (together with Polilingua Limited v. Daniel Dines, et al, the "Derivative Litigations"). The Derivative Litigations are at an early stage; in each case the matter has been stayed, pending the outcome of the Court's decision on the defendants' motion to dismiss the Securities Action.

We have not recorded any accrual related to the aforementioned litigation matters as of April 30, 2024, as we believe a loss in these matters is neither probable nor estimable at this time.

Warranty

We warrant to customers that our platform will operate substantially in accordance with its specifications. Historically, no significant costs have been incurred related to product warranties. Based on such historical experience, the probability of incurring such costs in the future is deemed remote. As such, no accruals for product warranty costs have been made.

Other Matters

Our indirect tax positions are subject to audit in multiple jurisdictions globally, with a key focus on our largest operational territories, including the U.S., Romania, India, and the U.K. Our Romanian subsidiary was subjected to audits by the Agenția Națională de Administrare Fiscală ("ANAF") for value-added tax and corporate income tax for the periods January 2020 through January 2022 and January 2018 through January 2022, respectively, which were completed during the three months ended April 30, 2024. With regard to the value-added tax audit, an assessment has been issued; we disagree with this assessment and are in the process of appealing. We have not recorded any reserves related to this audit as of April 30, 2024 as it is not probable that a material loss has been incurred. For additional information regarding the corporate income tax audit, refer to Note 12, Income Taxes.

Non-Cancelable Purchase Obligations

In the normal course of business, we enter into non-cancelable purchase commitments with various parties, mainly for hosting services, software products and services, and credits toward purchase of products and services from strategic alliance partners.

As of April 30, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	66,202
Year ending January 31,
2026	69,593
2027	23,856
2028	8,443
2029	17
Thereafter	1
Total	$	168,112

XML

Stockholders' Equity

3 Months Ended

Apr. 30, 2024

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Stock Repurchase Program

On September 1, 2023, our board of directors authorized a stock repurchase program, pursuant to which we may repurchase from time to time up to $500.0 million of our outstanding shares of Class A common stock. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. This authorization expires on March 1, 2025, subject to modification by the board of directors in the future.

During the three months ended April 30, 2024, we repurchased 0.9 million shares of our Class A common stock at an average price of $23.46 per share (inclusive of brokerage commission).

Charitable Donations of Class A Common Stock

We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. We contributed 0.3 million shares of our Class A common stock during the three months ended April 30, 2024 and 0.3 million shares of our Class A common stock during the three months ended April 30, 2023 to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $6.6 million and $4.2 million were recorded within general and administrative expense in the condensed consolidated statements of operations for the three months ended April 30, 2024 and 2023, respectively.

Accumulated Other Comprehensive Income

For the three months ended April 30, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands):

	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2024	$	8,925	$	(100)	$	8,825
Other comprehensive loss, net of tax	(3,574)		(511)		(4,085)
Balance as of April 30, 2024	$	5,351	$	(611)	$	4,740

	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive income, net of tax	2,319		143		2,462
Balance as of April 30, 2023	$	10,550	$	(476)	$	10,074

XML

Equity Incentive Plans and Stock-Based Compensation

3 Months Ended

Apr. 30, 2024

Share-Based Payment Arrangement [Abstract]

Equity Incentive Plans and Stock-Based Compensation

Equity Incentive Plans and Stock-Based Compensation

2021 Stock Plan

In April 2021, prior to and in connection with our initial public offering ("IPO"), we adopted our 2021 Equity Incentive Plan (the "2021 Plan"), which provides for grants of incentive stock options, nonstatutory stock options, stock appreciation rights, RSAs, RSUs, PSUs, and other forms of awards. As of April 30, 2024, we have reserved 202.2 million shares of our Class A common stock to be issued under the 2021 Plan. The number of shares of our Class A common stock reserved for issuance under the 2021 Plan will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, in an amount equal to (1) 5% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31, or (2) a lesser number of shares determined by our board of directors no later than the February 1 increase.

2021 Employee Stock Purchase Plan

In April 2021, prior to and in connection with the IPO, we adopted our 2021 Employee Stock Purchase Plan (the “ESPP”). As of April 30, 2024, the ESPP authorizes the issuance of 27.2 million shares of our Class A common stock under purchase rights granted to our employees. The number of shares of our Class A common stock reserved for issuance will automatically increase on February 1 of each year for a period of ten years, which began on February 1, 2022 and continues through February 1, 2031, by the lesser of (1) 1% of the total number of shares of our common stock (both Class A and Class B) outstanding on the preceding January 31; and (2) 15.5 million shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth by (1) and (2) above. The ESPP allows participants to purchase shares at the lesser of (a) 85% of the fair market value of our Class A common stock as of the commencement of the offering period, and (b) 85% of the fair market value of our Class A common stock on the corresponding purchase date.

Stock Options

Stock option activity during the three months ended April 30, 2024 was as follows:

	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	11,080	$	3.49	7.8	$	216,010
Granted	1,670	$	0.10
Exercised	(1,428)	$	0.22
Forfeited	(40)	$	0.10
Outstanding as of April 30, 2024	11,282	$	3.41	8.0	$	175,549
Vested and exercisable as of April 30, 2024	4,779	$	5.09	6.8	$	66,332

The weighted-average grant date fair value of stock options granted during the three months ended April 30, 2024 was $21.26 per share. The intrinsic value of stock options exercised during the three months ended April 30, 2024 was $31.4 million.

Unrecognized compensation expense associated with unvested stock options granted and outstanding as of April 30, 2024 was approximately $122.5 million, which is to be recognized over a weighted-average remaining period of 2.2 years.

Restricted Stock Units

RSU activity during the three months ended April 30, 2024 was as follows:

	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	31,272	$	19.89
Granted	9,479	$	21.45
Vested	(3,843)	$	21.22
Forfeited	(1,497)	$	20.76
Unvested as of April 30, 2024	35,411	$	20.13

The fair value of RSUs released during the three months ended April 30, 2024 was $87.4 million.

As of April 30, 2024, total unrecognized compensation expense related to unvested RSUs was approximately $661.6 million, which is to be recognized over a weighted-average remaining period of 2.4 years.

Employee Stock Purchase Plan Awards

As of April 30, 2024, total unrecognized compensation expense related to the ESPP was approximately $0.9 million, which is to be recognized over a weighted-average remaining period of 0.1 years.

Stock-Based Compensation Associated with Business Acquisition

At the closing of the acquisition of Re:infer LTD on July 29, 2022, we issued 0.4 million shares of Class A common stock (outside of the 2021 Plan) to be released to certain employee sellers in equal installments on the first, second, and third anniversaries of the closing date, subject to employment-related clawback provisions. As of

April 30, 2024, total unrecognized compensation expense related to these shares was $3.2 million, which is to be recognized over a weighted-average remaining period of 1.3 years.

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cost of subscription services revenue	$	4,276	$	3,178
Cost of professional services and other revenue	2,470		2,699
Sales and marketing	36,216		33,123
Research and development	29,142		24,773
General and administrative	16,623		21,275
Total	$	88,727	$	85,048

XML

Income Taxes

3 Months Ended

Apr. 30, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Our tax provision for interim periods is determined using an estimated annual effective tax rate, adjusted for discrete items arising in the applicable quarter. In each quarter, we update the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to significant volatility due to several factors, including our ability to accurately predict the proportion of our pretax income in multiple jurisdictions and certain book-tax differences.

We had a provision for income taxes of $3.8 million, reflecting an effective tax rate of (15.1)%, and $3.6 million, reflecting an effective tax rate of (12.8)%, for the three months ended April 30, 2024 and 2023, respectively. For the three months ended April 30, 2024 and 2023, our effective tax rate differed from the U.S. federal statutory rate primarily as a result of not recognizing deferred tax assets ("DTAs") for losses due to a full valuation allowance (as discussed below) and due to tax rate differences between the U.S. and foreign countries.

The realization of tax benefits of net DTAs is dependent upon future levels of taxable income of an appropriate character in the periods the items are expected to be deductible or taxable. Based on the available objective evidence during the three months ended April 30, 2024, we believe it is more likely than not that the tax benefits of DTAs associated with the U.S., Romania, and the U.K. will not be realized. Accordingly, we have recorded a full valuation allowance against U.S., Romania, and U.K. DTAs. We intend to maintain each of these full valuation allowances until sufficient positive evidence exists to support a reversal of, or decrease in, the valuation allowance.

As of April 30, 2024, we had gross unrecognized tax benefits totaling $2.3 million related to income taxes, which would impact the effective tax rate if recognized. Of this amount, the total liability pertaining to uncertain tax positions was $0.5 million, excluding interest and penalties, which are accounted for as a component of our income tax provision. Our tax positions are subject to income tax audits in multiple tax jurisdictions globally, with a currently open audit in India, and we believe that we have provided adequate reserves for our income tax uncertainties in all open tax years. Our Romanian subsidiary was subjected to a corporate income tax audit by ANAF for the period from January 2018 through January 2022, which was completed during the three months ended April 30, 2024. Certain deductions have been disallowed, resulting in a proposed reduction of net operating loss carryforwards of approximately $66.7 million. We are in the process of appealing this disallowance. In addition, we have engaged in two bilateral transfer pricing negotiations for our transfer pricing model, one between the U.S. and Romania, and one between Japan and Romania. These negotiations are still underway and the authorities are in the process of determining the cost sharing allocations between the respective countries. At this time, we do not expect any significant changes in the next fiscal quarter based on the current positions undertaken by us.

In 2023, Romania adopted an alternative minimum tax that is applicable to all corporate taxpayers, including those reporting a net loss, for tax years commencing after January 1, 2024. As this tax is based on gross receipts,

associated expense is included in operating expenses in our condensed consolidated statements of operations, and is not accounted for as income taxes.

XML

Net Loss Per Share

3 Months Ended

Apr. 30, 2024

Earnings Per Share [Abstract]

Net Loss Per Share

Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):

	Three Months Ended April 30,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(24,579)	$	(4,157)	$	(27,186)	$	(4,715)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	487,472		82,453		475,425		82,453
Net loss per share, basic and diluted	$	(0.05)	$	(0.05)	$	(0.06)	$	(0.06)

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	32,230	—	37,351	—
Outstanding stock options	10,946	—	13,883	—
Shares subject to repurchase from RSAs and early exercised stock options	28	—	63	—
Shares issuable under ESPP	690	—	897	—
Returnable shares issued in connection with business acquisition	274	—	427	—
Total	44,168	—	52,621	—

XML

Subsequent Events

3 Months Ended

Apr. 30, 2024

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On May 3, 2024, we agreed to invest approximately $35.2 million, split between cash investment for equity and purchase of convertible bonds, in an initial seed round in H.AI (the “H company”), a France-based global foundation model and agentic artificial intelligence ("AI") company.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Apr. 30, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP may be condensed or omitted. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the accompanying notes thereto for the fiscal year ended January 31, 2024, which are included in the 2024 Form 10-K.

The unaudited condensed consolidated financial statements have been prepared on the same basis as our audited consolidated financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our financial information. The unaudited condensed consolidated financial statements include the financial statements of UiPath, Inc. and its subsidiaries in which we hold a controlling financial interest. Intercompany transactions and accounts have been eliminated in consolidation.

The results of operations for the three months ended April 30, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2025 or for any other future interim or annual period.

Fiscal Year

Fiscal Year

Our fiscal year ends on January 31. References to fiscal year 2025, for example, refer to the fiscal year ending January 31, 2025.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the balance sheet date and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, certain aspects of revenue recognition, expected period of benefit for deferred contract acquisition costs, allowance for credit losses, fair value of financial assets and liabilities, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets and operating lease liabilities, incremental borrowing rates for operating leases, amount of stock-based compensation expense, timing and amount of contingencies, costs related to our restructuring actions, uncertain tax positions, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.

Foreign Currency

Foreign Currency

The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using average monthly exchange rates. Differences are included in stockholders’ equity as a component of accumulated other comprehensive income. Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other income (expense), net in the condensed consolidated statements of operations.

Concentration of Risks

Concentration of Risks

Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable.

We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits. As of April 30, 2024 and January 31, 2024, 95% and 91%, respectively, of our cash and cash equivalents were concentrated in the U.S., European Union (“EU”) countries, and Japan.

The selection of investments in marketable securities is governed by our investment policy. The policy aims to emphasize principles of safety and liquidity, with the overall objective of earning an attractive rate of return while limiting exposure to risk of loss and avoiding inappropriate concentrations. We use this policy to guide our investment decisions as it stipulates, among other things, a list of eligible investment types, minimum ratings and other restrictions for each type, and overall portfolio composition constraints.

With regard to accounts receivable, we extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of creditworthiness and applying other credit risk monitoring procedures. Significant customers are those that represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU No. 2023-07 is intended to improve reportable segments disclosures requirements, primarily through enhanced disclosures about significant segment expenses. ASU No. 2023-07 will be effective for us for annual periods beginning after December 15, 2023 and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU No. 2023-09 will require additional tax disclosures, predominantly related to the effective income tax rate reconciliation and income taxes paid. ASU No. 2023-09 will be effective for us for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.

XML

Revenue Recognition (Tables)

3 Months Ended

Apr. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue by Geographical Region

The following tables summarize revenue by geographical region (dollars in thousands): 

	Three Months Ended April 30,
	2024				2023
	Amount		Percentage of Revenue		Amount		Percentage of Revenue
Americas (1)	$	153,111	46	%	$	123,452	43	%
Europe, Middle East, and Africa	104,627		31	%	96,931		33	%
Asia-Pacific (2)	77,374		23	%	69,205		24	%
Total revenue	$	335,112	100	%	$	289,588	100	%

(1)Revenue from the U.S. represented 42% and 38% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

(2)Revenue from Japan represented 13% and 13% of our total revenues for the three months ended April 30, 2024 and 2023, respectively.

XML

Marketable Securities (Tables)

3 Months Ended

Apr. 30, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Marketable Securities

The following is a summary of our marketable securities (in thousands): 

	As of April 30, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Commercial paper	$	978	$	—	$	—	$	978
Treasury bills and U.S. government securities(1)	710,071		—		(506)		709,565
Corporate bonds(2)	24,778		—		(60)		24,718
Agency bonds	54,661		—		(40)		54,621
Total marketable securities	$	790,488	$	—	$	(606)	$	789,882
(1) Additional treasury bills with both amortized cost and estimated fair value of $19.8 million are included in cash and cash equivalents due to their original maturity of three months or less.
(2) Additional corporate bonds with both amortized cost and estimated fair value of $6.1 million are included in cash and cash equivalents due to their original maturity of three months or less.

	As of January 31, 2024
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Estimated Fair Value
Treasury bills and U.S. government securities	641,263		29		(100)		641,192
Corporate bonds	1,993		—		(2)		1,991
Agency bonds	174,990		—		(28)		174,962
Total marketable securities	$	818,246	$	29	$	(130)	$	818,145

XML

Fair Value Measurement (Tables)

3 Months Ended

Apr. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

The following tables present the fair value hierarchy of our financial assets measured at fair value on a recurring basis as of April 30, 2024 and January 31, 2024 (in thousands): 

	As of April 30, 2024
	Level 1		Level 2		Total
Money market	$	499,276	$	—	$	499,276
Treasury bills	19,765		—		19,765
Corporate bonds	—		6,065		6,065
Total cash equivalents	519,041		6,065		525,106
Commercial paper	—		978		978
Treasury bills and U.S. government securities	709,565		—		709,565
Corporate bonds	—		24,718		24,718
Agency bonds	54,621		—		54,621
Total marketable securities	764,186		25,696		789,882
Total	$	1,283,227	$	31,761	$	1,314,988

	As of January 31, 2024
	Level 1		Level 2		Total
Money market	$	509,053	$	—	$	509,053
Total cash equivalents	509,053		—		509,053
Treasury bills and U.S. government securities	641,192		—		641,192
Corporate bonds	—		1,991		1,991
Agency bonds	174,962		—		174,962
Total marketable securities	816,154		1,991		818,145
Total	$	1,325,207	$	1,991	$	1,327,198

XML

Intangible Assets and Goodwill (Tables)

3 Months Ended

Apr. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Acquired intangible assets, net consisted of the following as of April 30, 2024 (dollars in thousands): 

	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,572	$	(18,166)	$	10,406	2.6
Customer relationships	8,228		(6,829)		1,399		1.2
Trade names and trademarks	271		(271)		—		0.0
Other intangibles	1,231		(459)		772		6.9
Total	$	38,302	$	(25,725)	$	12,577

Acquired intangible assets, net consisted of the following as of January 31, 2024 (dollars in thousands):

	Intangible Assets, Gross		Accumulated Amortization		Intangible Assets, Net		Weighted-Average Remaining Useful Life (years)
Developed technology	$	28,807	$	(16,881)	$	11,926	2.8
Customer relationships	8,266		(6,306)		1,960		1.3
Trade names and trademarks	272		(266)		6		0.2
Other intangibles	1,231		(419)		812		7.0
Total	$	38,576	$	(23,872)	$	14,704

Schedule of Expected Future Amortization Expenses Related to Intangible Assets

Expected future amortization expense related to intangible assets was as follows as of April 30, 2024 (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	4,615
Year ending January 31,
2026	4,079
2027	2,428
2028	1,153
2029	101
Thereafter	201
Total	$	12,577

Schedule of Changes in Carrying Amounts of Goodwill

Changes in the carrying amount of goodwill during the three months ended April 30, 2024 were as follows (in thousands):

	Carrying Amount
Balance as of January 31, 2024	$	89,026
Effect of foreign currency translation	(642)
Balance as of April 30, 2024	$	88,384

XML

Operating Leases (Tables)

3 Months Ended

Apr. 30, 2024

Leases [Abstract]

Schedule of Lease Costs and Supplemental Cash Flow Information

Lease costs are presented below (in thousands):

	Three Months Ended April 30,
	2024		2023
Operating lease cost	$	3,476	$	3,071
Short-term lease cost	1,123		1,300
Variable lease cost	523		621
Sublease income (1)	—		(532)
Total	$	5,122	$	4,460

(1) Included in other income, net in the condensed consolidated statements of operations.

Supplemental cash flow information related to leases for the three months ended April 30, 2024 and 2023 was as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cash paid for amounts included in the measurement of operating lease liabilities	$	3,653	$	2,615
Operating lease ROU assets obtained in exchange for new operating lease liabilities	7,044		1,993

Schedule of Weighted-average Lease Term and Discount Rate

The following table represents the weighted-average remaining lease term and discount rate as of the periods presented:

	As of
	April 30, 2024		January 31, 2024
Weighted-average remaining lease term (years)	10.5		10.7
Weighted-average discount rate	7.2	%	7.1	%

Schedule of Future Undiscounted Lease Payments for Operating Lease Liabilities

Future undiscounted lease payments for our operating lease liabilities as of April 30, 2024 were as follows (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	9,097
Year ending January 31,
2026	12,110
2027	11,875
2028	10,444
2029	7,137
Thereafter	49,852
Total operating lease payments	100,515
Less: imputed interest	(29,519)
Total operating lease liabilities	$	70,996

XML

Condensed Consolidated Balance Sheet Components (Tables)

3 Months Ended

Apr. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Prepaid expenses and service credits	$	76,695	$	87,781
Other current assets	21,451		17,199
Prepaid expenses and other current assets	$	98,146	$	104,980

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Computers and equipment	$	23,706	$	23,767
Leasehold improvements	24,307		21,756
Furniture and fixtures	6,708		6,640
Construction in progress	2,720		4,560
Other	631		632
Property and equipment, gross	58,072		57,355
Less: accumulated depreciation	(35,331)		(33,373)
Property and equipment, net	$	22,741	$	23,982

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	As of
	April 30, 2024		January 31, 2024
Accrued expenses	$	22,256	$	18,458
Withholding tax from employee equity transactions	4,216		3,277
Employee stock purchase plan withholdings	8,483		3,618
Payroll taxes and other benefits payable	5,424		3,888
Income taxes payable	6,833		7,140
Value-added taxes payable	3,837		6,480
Operating lease liabilities, current	8,224		8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024)	5,570		5,570
Rebates payable to partners	6,364		7,289
Other	13,586		19,920
Accrued expenses and other current liabilities	$	84,793	$	83,997

XML

Commitments and Contingencies (Tables)

3 Months Ended

Apr. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Non-Cancelable Purchase Obligations

As of April 30, 2024, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows (in thousands):

	Amount
Remainder of year ending January 31, 2025	$	66,202
Year ending January 31,
2026	69,593
2027	23,856
2028	8,443
2029	17
Thereafter	1
Total	$	168,112

XML

Stockholders' Equity (Tables)

3 Months Ended

Apr. 30, 2024

Equity [Abstract]

Schedule of Changes in Components of Accumulated Other Comprehensive Income

For the three months ended April 30, 2024 and 2023, changes in the components of accumulated other comprehensive income were as follows (in thousands):

	Foreign Currency Translation Adjustments		Unrealized Loss on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2024	$	8,925	$	(100)	$	8,825
Other comprehensive loss, net of tax	(3,574)		(511)		(4,085)
Balance as of April 30, 2024	$	5,351	$	(611)	$	4,740

	Foreign Currency Translation Adjustments		Unrealized Gain (Loss) on Marketable Securities		Accumulated Other Comprehensive Income
Balance as of January 31, 2023	$	8,231	$	(619)	$	7,612
Other comprehensive income, net of tax	2,319		143		2,462
Balance as of April 30, 2023	$	10,550	$	(476)	$	10,074

XML

Equity Incentive Plans and Stock-Based Compensation (Tables)

3 Months Ended

Apr. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

Stock option activity during the three months ended April 30, 2024 was as follows:

	Stock Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2024	11,080	$	3.49	7.8	$	216,010
Granted	1,670	$	0.10
Exercised	(1,428)	$	0.22
Forfeited	(40)	$	0.10
Outstanding as of April 30, 2024	11,282	$	3.41	8.0	$	175,549
Vested and exercisable as of April 30, 2024	4,779	$	5.09	6.8	$	66,332

Schedule of RSU Activity

RSU activity during the three months ended April 30, 2024 was as follows:

	RSUs (in thousands)	Weighted-Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	31,272	$	19.89
Granted	9,479	$	21.45
Vested	(3,843)	$	21.22
Forfeited	(1,497)	$	20.76
Unvested as of April 30, 2024	35,411	$	20.13

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is classified in the condensed consolidated statements of operations as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
Cost of subscription services revenue	$	4,276	$	3,178
Cost of professional services and other revenue	2,470		2,699
Sales and marketing	36,216		33,123
Research and development	29,142		24,773
General and administrative	16,623		21,275
Total	$	88,727	$	85,048

XML

Net Loss Per Share (Tables)

3 Months Ended

Apr. 30, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands except per share amounts):

	Three Months Ended April 30,
	2024				2023
	Class A		Class B		Class A		Class B
Numerator:
Net loss	$	(24,579)	$	(4,157)	$	(27,186)	$	(4,715)
Denominator:
Weighted-average shares used in computing net loss per share, basic and diluted	487,472		82,453		475,425		82,453
Net loss per share, basic and diluted	$	(0.05)	$	(0.05)	$	(0.06)	$	(0.06)

Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share

Anti-dilutive common stock equivalents excluded from the computation of diluted net loss per share were as follows (in thousands):

	Three Months Ended April 30,
	2024		2023
	Class A	Class B	Class A	Class B
Unvested RSUs	32,230	—	37,351	—
Outstanding stock options	10,946	—	13,883	—
Shares subject to repurchase from RSAs and early exercised stock options	28	—	63	—
Shares issuable under ESPP	690	—	897	—
Returnable shares issued in connection with business acquisition	274	—	427	—
Total	44,168	—	52,621	—

XML

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Summary Of Significant Accounting Policies [Line Items]
Foreign currency transaction gain (losses)	$ 2.8	$ (0.8)
United States, European Union Countries and Japan | Geographic Concentration Risk | Cash and Cash Equivalents
Summary Of Significant Accounting Policies [Line Items]
Concentration risk, percentage	95.00%		91.00%

XML

Revenue Recognition - Disaggregation of Revenue by Geographical Region (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Amount	$ 335,112	$ 289,588
Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100.00%	100.00%
Americas
Disaggregation of Revenue [Line Items]
Amount	$ 153,111	$ 123,452
Americas | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	46.00%	43.00%
Europe, Middle East, and Africa
Disaggregation of Revenue [Line Items]
Amount	$ 104,627	$ 96,931
Europe, Middle East, and Africa | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	31.00%	33.00%
Asia-Pacific
Disaggregation of Revenue [Line Items]
Amount	$ 77,374	$ 69,205
Asia-Pacific | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	23.00%	24.00%
United States | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	42.00%	38.00%
Japan | Revenue | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	13.00%	13.00%

XML

Revenue Recognition - Deferred Revenue and Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 182,300	$ 150,600
Deferred contract acquisition costs	$ 18,467	$ 14,072

XML

Revenue Recognition - Remaining Performance Obligations (Details) $ in Millions	Apr. 30, 2024 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 1,100.6
Billed Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	616.2
Unbilled Consideration
Disaggregation of Revenue [Line Items]
Remaining performance obligations	$ 484.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-05-01
Disaggregation of Revenue [Line Items]
Remaining performance obligations, percentage	62.00%
Remaining performance obligations, period	12 months

XML

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 790,488	$ 818,246
Gross Unrealized Gains	0	29
Gross Unrealized Losses	(606)	(130)
Estimated Fair Value	789,882	818,145
Cash and cash equivalents, amortized cost	1,146,618	1,061,678
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	978
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	978
Treasury bills and U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	710,071	641,263
Gross Unrealized Gains	0	29
Gross Unrealized Losses	(506)	(100)
Estimated Fair Value	709,565	641,192
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	24,778	1,993
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(60)	(2)
Estimated Fair Value	24,718	1,991
Cash and cash equivalents, amortized cost	6,100
Cash and cash equivalents, fair value	6,100
Agency bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	54,661	174,990
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(40)	(28)
Estimated Fair Value	54,621	$ 174,962
Treasury bills
Debt Securities, Available-for-sale [Line Items]
Cash and cash equivalents, amortized cost	19,800
Cash and cash equivalents, fair value	$ 19,800

XML

Marketable Securities - Additional Information (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Marketable securities with contractual maturities of one year or more	$ 962	$ 0
Interest receivable	$ 3,100	$ 3,300

XML

Fair Value Measurement (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Financial assets:
Total marketable securities	$ 789,882	$ 818,145
Treasury bills
Financial assets:
Total cash equivalents	19,800
Corporate bonds
Financial assets:
Total cash equivalents	6,100
Total marketable securities	24,718	1,991
Commercial paper
Financial assets:
Total marketable securities	978
Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	709,565	641,192
Agency bonds
Financial assets:
Total marketable securities	54,621	174,962
Recurring
Financial assets:
Total cash equivalents	525,106	509,053
Total marketable securities	789,882	818,145
Total	1,314,988	1,327,198
Recurring | Money market
Financial assets:
Total cash equivalents	499,276	509,053
Recurring | Treasury bills
Financial assets:
Total cash equivalents	19,765
Recurring | Corporate bonds
Financial assets:
Total cash equivalents	6,065
Total marketable securities	24,718	1,991
Recurring | Commercial paper
Financial assets:
Total marketable securities	978
Recurring | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	709,565	641,192
Recurring | Agency bonds
Financial assets:
Total marketable securities	54,621	174,962
Recurring | Level 1
Financial assets:
Total cash equivalents	519,041	509,053
Total marketable securities	764,186	816,154
Total	1,283,227	1,325,207
Recurring | Level 1 | Money market
Financial assets:
Total cash equivalents	499,276	509,053
Recurring | Level 1 | Treasury bills
Financial assets:
Total cash equivalents	19,765
Recurring | Level 1 | Corporate bonds
Financial assets:
Total cash equivalents	0
Total marketable securities	0	0
Recurring | Level 1 | Commercial paper
Financial assets:
Total marketable securities	0
Recurring | Level 1 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	709,565	641,192
Recurring | Level 1 | Agency bonds
Financial assets:
Total marketable securities	54,621	174,962
Recurring | Level 2
Financial assets:
Total cash equivalents	6,065	0
Total marketable securities	25,696	1,991
Total	31,761	1,991
Recurring | Level 2 | Money market
Financial assets:
Total cash equivalents	0	0
Recurring | Level 2 | Treasury bills
Financial assets:
Total cash equivalents	0
Recurring | Level 2 | Corporate bonds
Financial assets:
Total cash equivalents	6,065
Total marketable securities	24,718	1,991
Recurring | Level 2 | Commercial paper
Financial assets:
Total marketable securities	978
Recurring | Level 2 | Treasury bills and U.S. government securities
Financial assets:
Total marketable securities	0	0
Recurring | Level 2 | Agency bonds
Financial assets:
Total marketable securities	0	0
Recurring | Level 3
Financial assets:
Total	$ 0	$ 0

XML

Intangible Assets and Goodwill - Summary of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 38,302	$ 38,576
Accumulated Amortization	(25,725)	(23,872)
Intangible Assets, Net	12,577	14,704
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	28,572	28,807
Accumulated Amortization	(18,166)	(16,881)
Intangible Assets, Net	$ 10,406	$ 11,926
Weighted-Average Remaining Useful Life (years)	2 years 7 months 6 days	2 years 9 months 18 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 8,228	$ 8,266
Accumulated Amortization	(6,829)	(6,306)
Intangible Assets, Net	$ 1,399	$ 1,960
Weighted-Average Remaining Useful Life (years)	1 year 2 months 12 days	1 year 3 months 18 days
Trade names and trademarks
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 271	$ 272
Accumulated Amortization	(271)	(266)
Intangible Assets, Net	$ 0	$ 6
Weighted-Average Remaining Useful Life (years)	0 years	2 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Gross	$ 1,231	$ 1,231
Accumulated Amortization	(459)	(419)
Intangible Assets, Net	$ 772	$ 812
Weighted-Average Remaining Useful Life (years)	6 years 10 months 24 days	7 years

XML

Intangible Assets and Goodwill - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of acquired intangible assets	$ 2.0	$ 2.1

XML

Intangible Assets and Goodwill - Summary of Expected Future Amortization Expenses Related to Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of year ending January 31, 2025	$ 4,615
2026	4,079
2027	2,428
2028	1,153
2029	101
Thereafter	201
Intangible Assets, Net	$ 12,577	$ 14,704

XML

Intangible Assets and Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2024 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 89,026
Effect of foreign currency translation	(642)
Ending balance	$ 88,384

XML

Operating Leases - Additional Information (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Lessee, Lease, Description [Line Items]
Non-cancellable commitments for operating leases that have not yet commenced	$ 26,300
Current operating lease liabilities	$ 8,224	$ 8,357
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities
Minimum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease remaining lease terms	14 years

XML

Operating Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Operating lease cost	$ 3,476	$ 3,071
Short-term lease cost	1,123	1,300
Variable lease cost	523	621
Sublease income	0	(532)
Total	$ 5,122	$ 4,460

XML

Operating Leases - Weighted Average Lease Term and Discount Rate (Details)	Apr. 30, 2024	Jan. 31, 2024
Leases [Abstract]
Weighted-average remaining lease term (years)	10 years 6 months	10 years 8 months 12 days
Weighted-average discount rate	7.20%	7.10%

XML

Operating Leases - Summary of Future Undiscounted Lease Payments for Operating Lease Liabilities (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Leases [Abstract]
Remainder of year ending January 31, 2025	$ 9,097
2026	12,110
2027	11,875
2028	10,444
2029	7,137
Thereafter	49,852
Total operating lease payments	100,515
Less: imputed interest	(29,519)
Total operating lease liabilities	$ 70,996

XML

Operating Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 3,653	$ 2,615
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 7,044	$ 1,993

XML

Condensed Consolidated Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses and service credits	$ 76,695	$ 87,781
Other current assets	21,451	17,199
Prepaid expenses and other current assets	$ 98,146	$ 104,980

XML

Condensed Consolidated Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 58,072	$ 57,355
Less: accumulated depreciation	(35,331)	(33,373)
Property and equipment, net	22,741	23,982
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	23,706	23,767
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	24,307	21,756
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,708	6,640
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,720	4,560
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 631	$ 632

XML

Condensed Consolidated Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.3	$ 3.0

XML

Condensed Consolidated Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2024	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued expenses	$ 22,256	$ 18,458
Withholding tax from employee equity transactions	4,216	3,277
Employee stock purchase plan withholdings	8,483	3,618
Payroll taxes and other benefits payable	5,424	3,888
Income taxes payable	6,833	7,140
Value-added taxes payable	3,837	6,480
Operating lease liabilities, current	8,224	8,357
Loan note related to fiscal year 2023 acquisition of Re:Infer LTD (payable July 29, 2024)	5,570	5,570
Rebates payable to partners	6,364	7,289
Other	13,586	19,920
Accrued expenses and other current liabilities	$ 84,793	$ 83,997

XML

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Jan. 31, 2024
Other Commitments [Line Items]
Letters of credit outstanding	$ 2.8		$ 2.6
Defined contribution plan, contribution cost	6.2	$ 5.6
Litigation Matters
Other Commitments [Line Items]
Loss contingency accrual	0.0
Product Liability Contingencies
Other Commitments [Line Items]
Loss contingency accrual	0.0
Other Matters
Other Commitments [Line Items]
Loss contingency accrual	$ 0.0

XML

Commitments and Contingencies - Schedule of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Apr. 30, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of year ending January 31, 2025	$ 66,202
2026	69,593
2027	23,856
2028	8,443
2029	17
Thereafter	1
Total	$ 168,112

XML

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023	Sep. 01, 2023
Class of Stock [Line Items]
Charitable contribution recorded as expense	$ 6,564,000	$ 4,215,000
Common Stock | Class A Common Stock
Class of Stock [Line Items]
Repurchase authorized			$ 500,000,000
Repurchased of common shares (in shares)	900
Average price of common shares (in dollar per share)	$ 23.46
Common stock shares reserved to fund social impact and environmental, social and governance initiatives (in shares)	2,800
Charitable donation of Class A common stock (in shares)	281	281

XML

Stockholders' Equity - Summary of Changes In Components of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 2,016,114	$ 1,920,158
Other comprehensive (loss) income, net of tax	(4,085)	2,462
Ending balance	2,027,004	1,955,537
Accumulated Other Comprehensive Income
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,825	7,612
Other comprehensive (loss) income, net of tax	(4,085)	2,462
Ending balance	4,740	10,074
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,925	8,231
Other comprehensive (loss) income, net of tax	(3,574)	2,319
Ending balance	5,351	10,550
Unrealized Loss on Marketable Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(100)	(619)
Other comprehensive (loss) income, net of tax	(511)	143
Ending balance	$ (611)	$ (476)

XML

Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		1 Months Ended	3 Months Ended
	Jul. 29, 2022	Apr. 22, 2021	Apr. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of stock options granted (in dollars per share)			$ 21.26
Intrinsic value of stock options exercised			$ 31.4
Cost not yet recognized for unvested options			$ 122.5
Re:infer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			1 year 3 months 18 days
Unrecognized compensation expense			$ 3.2
Stock issued at closing subject to clawback provisions (in shares)	0.4
Shares issuable under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)		15.5
Period of shares automatically increase		10 years
Percentage of total number of shares		1.00%
Number of shares authorized (in shares)			27.2
Weighted-average remaining period			1 month 6 days
Unrecognized compensation expense			$ 0.9
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			2 years 2 months 12 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period			2 years 4 months 24 days
Fair value of RSUs vested			$ 87.4
Unrecognized compensation expense			$ 661.6
Class A Common Stock | Shares issuable under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, offering date, percent of market price		85.00%
Purchase price of common stock, purchase date, percent of market price		85.00%
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of shares automatically increase		10 years
Percentage of total number of shares		5.00%
2021 Stock Plan | Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuances (in shares)			202.2

XML

Equity Incentive Plans and Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2024	Jan. 31, 2024
Stock Options
Outstanding, beginning balance (in shares)	11,080
Granted (in shares)	1,670
Exercised (in shares)	(1,428)
Forfeited (in shares)	(40)
Outstanding, ending balance (in shares)	11,282	11,080
Weighted-Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 3.49
Granted (in dollars per share)	0.10
Exercised (in dollars per share)	0.22
Forfeited (in dollars per share)	0.10
Outstanding, ending balance (in dollars per share)	$ 3.41	$ 3.49
Outstanding, Weighted-Average Remaining Contractual Life (years)	8 years	7 years 9 months 18 days
Outstanding, Aggregate Intrinsic Value	$ 175,549	$ 216,010
Vested and exercisable, Stock Options (in shares)	4,779
Vested and exercisable, Weighted-Average Exercise Price (in dollars per share)	$ 5.09
Vested and exercisable, Weighted-Average Remaining Contractual Life (years)	6 years 9 months 18 days
Vested and exercisable, Aggregate Intrinsic Value	$ 66,332

XML

Equity Incentive Plans and Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units shares in Thousands	3 Months Ended
	Apr. 30, 2024 $ / shares shares
RSUs
Unvested, beginning balance (in shares) | shares	31,272
Granted (in shares) | shares	9,479
Vested (in shares) | shares	(3,843)
Forfeited (in shares) | shares	(1,497)
Unvested, ending balance (in shares) | shares	35,411
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 19.89
Granted (in dollars per share) | $ / shares	21.45
Vested (in dollars per share) | $ / shares	21.22
Forfeited (in dollars per share) | $ / shares	20.76
Unvested, ending balance (in dollars per share) | $ / shares	$ 20.13

XML

Equity Incentive Plans and Stock-based Compensation - Summary of Stock-Based Compensation Expense in Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 88,727	$ 85,048
Cost of revenue | Subscription services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	4,276	3,178
Cost of revenue | Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,470	2,699
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	36,216	33,123
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	29,142	24,773
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 16,623	$ 21,275

XML

Income Taxes (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2024 USD ($) negotiation	Apr. 30, 2023 USD ($)
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 3,780	$ 3,632
Effective tax rate	(15.10%)	(12.80%)
Unrecognized tax benefits which would impact the effective tax rate if recognized	$ 2,300
Liability pertaining to uncertain tax positions	$ 500
Number of bilateral transfer pricing negotiations | negotiation	2
Romania | Subsidiaries
Income Tax Examination [Line Items]
Proposed reduction in NOLs	$ 66,700

XML

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (28,736)	$ (31,901)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	569,925	557,878
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	569,925	557,878
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)
Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (24,579)	$ (27,186)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	487,472	475,425
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	487,472	475,425
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)
Class B
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (4,157)	$ (4,715)
Denominator:
Weighted-average shares used in computing net loss per share, basic (in shares)	82,453	82,453
Net loss per share, basic (in dollars per share)	$ (0.05)	$ (0.06)
Denominator:
Weighted-average shares used in computing net loss per share, diluted (in shares)	82,453	82,453
Net loss per share, diluted (in dollars per share)	$ (0.05)	$ (0.06)

XML

Net Loss Per Share - Schedule of Anti-Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Class A
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	44,168	52,621
Class A | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	32,230	37,351
Class A | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	10,946	13,883
Class A | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	28	63
Class A | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	690	897
Class A | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	274	427
Class B
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Shares subject to repurchase from RSAs and early exercised stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Shares issuable under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0
Class B | Returnable shares issued in connection with business acquisition
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive common stock equivalents (in shares)	0	0

XML

Subsequent Events (Details) $ in Millions	May 03, 2024 USD ($)
Subsequent Event
Subsequent Event [Line Items]
Investments	$ 35.2